BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716-723. [PMID: 16585449 DOI: 10.1176/ajp.2006.163.4.716] [Cited by in Crossref: 1645] [Cited by in F6Publishing: 1546] [Article Influence: 102.8] [Reference Citation Analysis]
Number Citing Articles
1 Koh JEW, Ooi CP, Lim-Ashworth NS, Vicnesh J, Tor HT, Lih OS, Tan RS, Acharya UR, Fung DSS. Automated classification of attention deficit hyperactivity disorder and conduct disorder using entropy features with ECG signals. Comput Biol Med 2021;140:105120. [PMID: 34896884 DOI: 10.1016/j.compbiomed.2021.105120] [Reference Citation Analysis]
2 Higuchi Y, Inagaki M, Koyama T, Kitamura Y, Sendo T, Fujimori M, Uchitomi Y, Yamada N. A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan. BMC Public Health 2016;16:534. [PMID: 27392676 DOI: 10.1186/s12889-016-3208-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
3 Manoli A, Liversedge SP, Sonuga-Barke EJS, Hadwin JA. The Differential Effect of Anxiety and ADHD Symptoms on Inhibitory Control and Sustained Attention for Threat Stimuli: A Go/No-Go Eye-Movement Study. J Atten Disord 2021;25:1919-30. [PMID: 32513052 DOI: 10.1177/1087054720930809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Weibel S, Jermann F, Weiner L, Nicastro R, Ardu S, Pham E, Hasler R, Dayer A, Prada P, Perroud N. Insomnia in adult attention-deficit/hyperactivity disorder: A comparison with borderline personality disorder population in a clinical setting and control participants. Compr Psychiatry 2017;76:119-28. [PMID: 28501733 DOI: 10.1016/j.comppsych.2017.04.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wei YJ, Zhu Y, Liu W, Bussing R, Winterstein AG. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder. JAMA Netw Open 2018;1:e181152. [PMID: 30646105 DOI: 10.1001/jamanetworkopen.2018.1152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 Miller EM, Quintero JE, Pomerleau F, Huettl P, Gerhardt GA, Glaser PEA. Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD. Neurochem Res 2019;44:89-101. [PMID: 29397534 DOI: 10.1007/s11064-018-2483-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Perroud N, Hasler R, Golay N, Zimmermann J, Prada P, Nicastro R, Aubry JM, Ardu S, Herrmann FR, Giannakopoulos P, Baud P. Personality profiles in adults with attention deficit hyperactivity disorder (ADHD). BMC Psychiatry 2016;16:199. [PMID: 27301261 DOI: 10.1186/s12888-016-0906-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Rosch KS, Mostofsky S. Development of the frontal lobe. Handb Clin Neurol 2019;163:351-67. [PMID: 31590741 DOI: 10.1016/B978-0-12-804281-6.00019-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Carbonneau R, Vitaro F, Brendgen M, Tremblay RE. The Intergenerational Association Between Parents' Problem Gambling and Impulsivity-Hyperactivity/Inattention Behaviors in Children. J Abnorm Child Psychol 2018;46:1203-15. [PMID: 29101590 DOI: 10.1007/s10802-017-0362-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Pehlivanidis A, Papanikolaou K, Spyropoulou AC, Papadimitriou GN. Comorbid attention-deficit/hyperactivity disorder in adult psychiatric outpatients with depressive or anxiety disorders. International Journal of Psychiatry in Clinical Practice 2014;18:265-71. [DOI: 10.3109/13651501.2014.941878] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
11 Becker SP, Holdaway AS, Luebbe AM. Suicidal Behaviors in College Students: Frequency, Sex Differences, and Mental Health Correlates Including Sluggish Cognitive Tempo. J Adolesc Health 2018;63:181-8. [PMID: 30153929 DOI: 10.1016/j.jadohealth.2018.02.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
12 Dresler T, Ehlis AC, Heinzel S, Renner TJ, Reif A, Baehne CG, Heine M, Boreatti-Hümmer A, Jacob CP, Lesch KP, Fallgatter AJ. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. Neuropsychopharmacology 2010;35:2193-202. [PMID: 20631685 DOI: 10.1038/npp.2010.91] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
13 Nicastro R, Desseilles M, Prada P, Weibel S, Perroud N, Gex-Fabry M. Subjective Distress Associated with Adult ADHD: evaluation of a new self-report. Atten Defic Hyperact Disord 2018;10:77-86. [PMID: 28601956 DOI: 10.1007/s12402-017-0234-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Salem H, Vivas D, Cao F, Kazimi IF, Teixeira AL, Zeni CP. ADHD is associated with migraine: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 2018;27:267-77. [DOI: 10.1007/s00787-017-1045-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
15 Glöckner-rist A, Pedersen A, Rist F. Conceptual Structure of the Symptoms of Adult ADHD According to the DSM-IV and Retrospective Wender-Utah Criteria. J Atten Disord 2013;17:114-27. [DOI: 10.1177/1087054711427397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
16 Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Drug Alcohol Rev. 2015;34:683-693. [PMID: 25790353 DOI: 10.1111/dar.12249] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
17 Ebejer JL, Duffy DL, van der Werf J, Wright MJ, Montgomery G, Gillespie NA, Hickie IB, Martin NG, Medland SE. Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits. Twin Res Hum Genet 2013;16:560-74. [PMID: 23527680 DOI: 10.1017/thg.2013.12] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
18 Biederman J, Fried R, DiSalvo M, Driscoll H, Green A, Biederman I, Woodworth KY, Faraone SV. A novel digital health intervention to improve patient engagement to stimulants in adult ADHD in the primary care setting: Preliminary findings from an open label study. Psychiatry Res 2020;291:113158. [PMID: 32559669 DOI: 10.1016/j.psychres.2020.113158] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Cross-Villasana F, Finke K, Hennig-Fast K, Kilian B, Wiegand I, Müller HJ, Möller HJ, Töllner T. The Speed of Visual Attention and Motor-Response Decisions in Adult Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry 2015;78:107-15. [PMID: 25773661 DOI: 10.1016/j.biopsych.2015.01.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
20 Lee DY, Lee CS, Park CS, Kim BJ, Cha BS, Lee SJ, Bhang SY. Effect of symptoms of adult attention deficit hyperactivity disorder on symptoms of post traumatic stress disorder in Korean conscripts. Psychiatry Investig 2012;9:154-60. [PMID: 22707966 DOI: 10.4306/pi.2012.9.2.154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:456-63. [PMID: 15737659 DOI: 10.1016/j.biopsych.2004.11.043] [Cited by in Crossref: 233] [Cited by in F6Publishing: 188] [Article Influence: 13.7] [Reference Citation Analysis]
22 Corbisiero S, Bitto H, Newark P, Abt-Mörstedt B, Elsässer M, Buchli-Kammermann J, Künne S, Nyberg E, Hofecker-Fallahpour M, Stieglitz RD. A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial. Front Psychiatry 2018;9:571. [PMID: 30505283 DOI: 10.3389/fpsyt.2018.00571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Weisler RH, Babcock T, Adeyi B, Brams M. Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate. Postgrad Med 2014;126:31-41. [PMID: 25295648 DOI: 10.3810/pgm.2014.09.2798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Kim EJ, Kwon YJ, Lee HY, Yoon HJ, Kim JS, Shim SH. The Relationship Between Response-Inhibitory Event-Related Potentials and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adult Patients with Major Depressive Disorder. Psychiatry Investig 2020;17:996-1005. [PMID: 33045796 DOI: 10.30773/pi.2020.0074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Knotkova H, Clayton A, Stevens M, Riggs A, Charvet LE, Bikson M. Home-Based Patient-Delivered Remotely Supervised Transcranial Direct Current Stimulation. In: Knotkova H, Nitsche MA, Bikson M, Woods AJ, editors. Practical Guide to Transcranial Direct Current Stimulation. Cham: Springer International Publishing; 2019. pp. 379-405. [DOI: 10.1007/978-3-319-95948-1_13] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Ilie G, Vingilis ER, Mann RE, Hamilton H, Toplak M, Adlaf EM, Kolla N, Ialomiteanu A, van der Mass M, Asbridge M, Vingilis-jaremko L, Rehm J, Cusimano MD. The association between traumatic brain injury and ADHD in a Canadian adult sample. Journal of Psychiatric Research 2015;69:174-9. [DOI: 10.1016/j.jpsychires.2015.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
27 Fogler JM, Burke D, Lynch J, Barbaresi WJ, Chan E. Topical Review: Transitional Services for Teens and Young Adults With Attention-Deficit Hyperactivity Disorder: A Process Map and Proposed Model to Overcoming Barriers to Care. Journal of Pediatric Psychology 2017;42:1108-13. [DOI: 10.1093/jpepsy/jsx102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
28 Baykal S, Batar B, Nalbantoğlu A, Albayrak Y, Hancı H, Potas N, Durankuş F, Beyazyüz M, Karabekiroğlu K. Altered methyltetrahydrofolate reductase gene polymorphism in mothers of children with attention deficit and hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;88:215-21. [DOI: 10.1016/j.pnpbp.2018.07.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Conejero I, Jaussent I, Lopez R, Guillaume S, Olié E, Hebbache C, Cohen RF, Kahn JP, Leboyer M, Courtet P, Lopez-Castroman J. Association of symptoms of attention deficit-hyperactivity disorder and impulsive-aggression with severity of suicidal behavior in adult attempters. Sci Rep 2019;9:4593. [PMID: 30872743 DOI: 10.1038/s41598-019-41046-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
30 Ribasés M, Sánchez-mora C, Ramos-quiroga JA, Bosch R, Gómez N, Nogueira M, Corrales M, Palomar G, Jacob CP, Gross-lesch S, Kreiker S, Reif A, Lesch KP, Cormand B, Casas M, Bayés M. An association study of sequence variants in the forkhead box P2 (FOXP2) gene and adulthood attention-deficit/hyperactivity disorder in two European samples. Psychiatric Genetics 2012;22:155-60. [DOI: 10.1097/ypg.0b013e328353957e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Castells X, Blanco-Silvente L, Cunill R. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 2018;8:CD007813. [PMID: 30091808 DOI: 10.1002/14651858.CD007813.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
32 Philipsen A, Richter H, Peters J, Alm B, Sobanski E, Colla M, Münzebrock M, Scheel C, Jacob C, Perlov E, Tebartz van Elst L, Hesslinger B. Structured Group Psychotherapy in Adults With Attention Deficit Hyperactivity Disorder: Results of An Open Multicentre Study. Journal of Nervous & Mental Disease 2007;195:1013-9. [DOI: 10.1097/nmd.0b013e31815c088b] [Cited by in Crossref: 120] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
33 Sharma MJ, Lavoie S, Callahan BL. A Call for Research on the Validity of the Age-of-Onset Criterion Application in Older Adults Being Evaluated for ADHD: A Review of the Literature in Clinical and Cognitive Psychology. The American Journal of Geriatric Psychiatry 2021;29:669-78. [DOI: 10.1016/j.jagp.2020.10.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Kamradt JM, Momany AM, Nikolas MA. A meta-analytic review of the association between cortisol reactivity in response to a stressor and attention-deficit hyperactivity disorder. Atten Defic Hyperact Disord 2018;10:99-111. [PMID: 28875432 DOI: 10.1007/s12402-017-0238-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
35 Çelebi F, Koyuncu A, Ertekin E, Alyanak B, Tükel R. The Features of Comorbidity of Childhood ADHD in Patients With Obsessive Compulsive Disorder. J Atten Disord 2020;24:973-80. [PMID: 27650395 DOI: 10.1177/1087054716669228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Dagistan AA, Gica S, Aydin A, Cilli AS. Prevalence of probable attention-deficit/hyperactivity disorder in inmates and its relationship with recidivism. J Forensic Sci 2021. [PMID: 34596242 DOI: 10.1111/1556-4029.14894] [Reference Citation Analysis]
37 Bahn GH, Lee YS, Yoo HK, Kim EJ, Park S, Han DH, Hong M, Kim B, Lee SI, Bhang SY, Lee SY, Hong JP, Joung YS. Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder. Soa Chongsonyon Chongsin Uihak 2020;31:5-25. [PMID: 32612409 DOI: 10.5765/jkacap.190030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
38 Harmanci H, Çam Çelikel F, Etikan İ. Comorbidity of Adult Attention Deficit and Hyperactivity Disorder in Bipolar and Unipolar Patients. Noro Psikiyatr Ars 2016;53:257-62. [PMID: 28373804 DOI: 10.5152/npa.2015.11328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
39 Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 2011;20:17-37. [PMID: 21042924 DOI: 10.1007/s00787-010-0140-6] [Cited by in Crossref: 242] [Cited by in F6Publishing: 179] [Article Influence: 20.2] [Reference Citation Analysis]
40 González RA, Vélez-Pastrana MC, Ruiz Varcárcel JJ, Levin FR, Albizu-García CE. Childhood ADHD symptoms are associated with lifetime and current illicit substance-use disorders and in-site health risk behaviors in a representative sample of Latino prison inmates. J Atten Disord 2015;19:301-12. [PMID: 23212598 DOI: 10.1177/1087054712461690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
41 Pimus I, Peleg M, Schertz M. Sequence Mining of Comorbid Neurodevelopmental Disorders Using the SPADE Algorithm. Methods Inf Med 2016;55:223-33. [PMID: 26848079 DOI: 10.3414/ME15-01-0142] [Reference Citation Analysis]
42 Peterson K, McDonagh MS, Fu R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 2008;197:1-11. [PMID: 18026719 DOI: 10.1007/s00213-007-0996-4] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 5.4] [Reference Citation Analysis]
43 Fiksdal Abel K, Ravndal E, Clausen T, Bramness JG. Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment. Eur Addict Res 2017;23:298-305. [PMID: 29320768 DOI: 10.1159/000484240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Ali N, Caceres A, Hall EW, Laney D. Attention Deficits and ADHD Symptoms in Adults with Fabry Disease-A Pilot Investigation. J Clin Med 2021;10:3367. [PMID: 34362157 DOI: 10.3390/jcm10153367] [Reference Citation Analysis]
45 Hauck TS, Lau C, Wing LLF, Kurdyak P, Tu K. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors. Can J Psychiatry 2017;62:393-402. [PMID: 28103079 DOI: 10.1177/0706743716689055] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
46 Steele CM, Wymbs BT, Capps RE. Birds of a Feather: An Examination of ADHD Symptoms and Associated Concerns in Partners of Adults with ADHD. J Atten Disord 2022;26:296-306. [PMID: 33322995 DOI: 10.1177/1087054720978553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Agha SS, Zammit S, Thapar A, Langley K. Are parental ADHD problems associated with a more severe clinical presentation and greater family adversity in children with ADHD? Eur Child Adolesc Psychiatry 2013;22:369-77. [PMID: 23385540 DOI: 10.1007/s00787-013-0378-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
48 Sedgwick JA. University students with attention deficit hyperactivity disorder (ADHD): a literature review. Ir J Psychol Med 2018;35:221-35. [PMID: 30124182 DOI: 10.1017/ipm.2017.20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
49 Paslakis G, Kiefer F, Diehl A, Alm B, Sobanski E. Methylphenidat: Therapieoption bei ADHS und Suchterkrankung im Erwachsenenalter? Nervenarzt 2010;81:277-88. [DOI: 10.1007/s00115-009-2916-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Wilens TE, Biederman J, Faraone SV, Martelon M, Westerberg D, Spencer TJ. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry 2009;70:1557-62. [PMID: 20031097 DOI: 10.4088/JCP.08m04785pur] [Cited by in Crossref: 140] [Cited by in F6Publishing: 51] [Article Influence: 11.7] [Reference Citation Analysis]
51 Ekinci S, Ozdel K, Oncü B, Colak B, Kandemir H, Canat S. Temperamental characteristics in adults with attention-deficit hyperactivity disorder: a comparison with bipolar disorder and healthy control groups. Psychiatry Investig 2013;10:137-42. [PMID: 23798961 DOI: 10.4306/pi.2013.10.2.137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
52 Hong S, Kim J, Choi B, Hong Y, Park E, Shin M, Kim B, Yoo H, Cho I, Bhang S, Cho S. Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention-deficit/hyperactivity disorder. Psychiatry Research 2014;220:418-25. [DOI: 10.1016/j.psychres.2014.05.049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
53 Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev 2018;87:255-70. [PMID: 29428394 DOI: 10.1016/j.neubiorev.2018.02.001] [Cited by in Crossref: 147] [Cited by in F6Publishing: 108] [Article Influence: 36.8] [Reference Citation Analysis]
54 Holroyd CB, Umemoto A. The research domain criteria framework: The case for anterior cingulate cortex. Neuroscience & Biobehavioral Reviews 2016;71:418-43. [DOI: 10.1016/j.neubiorev.2016.09.021] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 17.0] [Reference Citation Analysis]
55 Nydén A, Niklasson L, Stahlberg O, Anckarsater H, Wentz E, Rastam M, Gillberg C. Adults with autism spectrum disorders and ADHD neuropsychological aspects. Res Dev Disabil 2010;31:1659-68. [PMID: 20537859 DOI: 10.1016/j.ridd.2010.04.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 5.7] [Reference Citation Analysis]
56 Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch KP, Jacob CP. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm (Vienna) 2009;116:121-30. [PMID: 18982239 DOI: 10.1007/s00702-008-0138-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
57 Epstein JN, Weiss MD. Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review. Prim Care Companion CNS Disord 2012;14:PCC. [PMID: 23585986 DOI: 10.4088/PCC.11r01336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
58 Instanes JT, Halmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K. Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases. Biol Psychiatry 2017;81:452-9. [PMID: 26809250 DOI: 10.1016/j.biopsych.2015.11.024] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 11.9] [Reference Citation Analysis]
59 Adler LA, Goodman D, Weisler R, Hamdani M, Roth T. Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder. Behav Brain Funct 2009;5:34. [PMID: 19650932 DOI: 10.1186/1744-9081-5-34] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
60 Golubchik P, Weizman A. Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review. Int Clin Psychopharmacol 2021;36:1-11. [PMID: 33086253 DOI: 10.1097/YIC.0000000000000338] [Reference Citation Analysis]
61 Gelo OCG, Lagetto G, Dinoi C, Belfiore E, Lombi E, Blasi S, Aria M, Ciavolino E. Which Methodological Practice(s) for Psychotherapy Science? A Systematic Review and a Proposal. Integr Psychol Behav Sci 2020;54:215-48. [PMID: 31240561 DOI: 10.1007/s12124-019-09494-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
62 Weisler RH. Emerging drugs for attention-deficit/hyperactivity disorder. Expert Opinion on Emerging Drugs 2007;12:423-34. [DOI: 10.1517/14728214.12.3.423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
63 Kleinman NL, Durkin M, Melkonian A, Markosyan K. Incremental employee health benefit costs, absence days, and turnover among employees with ADHD and among employees with children with ADHD. J Occup Environ Med 2009;51:1247-55. [PMID: 19858744 DOI: 10.1097/JOM.0b013e3181bca68c] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
64 Elwin M, Elvin T, Larsson JO. Symptoms and level of functioning related to comorbidity in children and adolescents with ADHD: a cross-sectional registry study. Child Adolesc Psychiatry Ment Health 2020;14:30. [PMID: 32760444 DOI: 10.1186/s13034-020-00336-4] [Reference Citation Analysis]
65 Bitter I, Simon V, Bálint S, Mészáros A, Czobor P. How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample. Eur Arch Psychiatry Clin Neurosci 2010;260:287-96. [PMID: 19806424 DOI: 10.1007/s00406-009-0076-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
66 Zhu J, Lee KP, Spencer TJ, Biederman J, Bhide PG. Transgenerational transmission of hyperactivity in a mouse model of ADHD. J Neurosci 2014;34:2768-73. [PMID: 24553919 DOI: 10.1523/JNEUROSCI.4402-13.2014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
67 Manor I, Rubin J, Daniely Y, Adler LA. Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD. Postgrad Med. 2014;126:7-16. [PMID: 25295645 DOI: 10.3810/pgm.2014.09.2795] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
68 Syed H, Masaud TM, Nkire N, Iro C, Garland MR. Estimating the prevalence of adult ADHD in the psychiatric clinic: a cross-sectional study using the adult ADHD self-report scale (ASRS). Ir j psychol Med 2010;27:195-7. [DOI: 10.1017/s079096670000152x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
69 Glass K, Flory K. Why does ADHD Confer Risk for Cigarette Smoking? A Review of Psychosocial Mechanisms. Clin Child Fam Psychol Rev 2010;13:291-313. [DOI: 10.1007/s10567-010-0070-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
70 Michielsen M, Kleef D, Bijlenga D, Zwennes C, Dijkhuizen K, Smulders J, Hazewinkel A, Beekman ATF, Kooij JJS. Response and Side Effects Using Stimulant Medication in Older Adults With ADHD: An Observational Archive Study. J Atten Disord 2021;25:1712-9. [PMID: 32508213 DOI: 10.1177/1087054720925884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Pettersson R, Söderström S, Nilsson KW. Diagnosing ADHD in Adults: An Examination of the Discriminative Validity of Neuropsychological Tests and Diagnostic Assessment Instruments. J Atten Disord 2018;22:1019-31. [DOI: 10.1177/1087054715618788] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
72 Schmidt S, Waldmann H, Petermann F, Brähler E. Wie stark sind Erwachsene mit ADHS und komorbiden Störungen in ihrer gesundheitsbezogenen Lebensqualität beeinträchtigt? Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2010;58:9-21. [DOI: 10.1024/1661-4747.a000002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
73 Delisi M, Vaughn M, Beaver KM, Wexler J, Barth AE, Fletcher JM. Fledgling Psychopathy in the Classroom: ADHD Subtypes Psychopathy, and Reading Comprehension in a Community Sample of Adolescents. Youth Violence Juv Justice 2011;9:43-58. [PMID: 21318082 DOI: 10.1177/1541204010371932] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
74 Riglin L, Leppert B, Langley K, Thapar AK, O'Donovan MC, Davey Smith G, Stergiakouli E, Tilling K, Thapar A. Investigating attention-deficit hyperactivity disorder and autism spectrum disorder traits in the general population: What happens in adult life? J Child Psychol Psychiatry 2021;62:449-57. [PMID: 32663329 DOI: 10.1111/jcpp.13297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Babinski DE, Pelham WE Jr, Molina BS, Gnagy EM, Waschbusch DA, Wymbs BT, Sibley MH, Derefinko KJ, Kuriyan AB. Maternal ADHD, Parenting, and Psychopathology Among Mothers of Adolescents With ADHD. J Atten Disord 2016;20:458-68. [PMID: 23160485 DOI: 10.1177/1087054712461688] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
76 Norén Selinus E, Molero Y, Lichtenstein P, Anckarsäter H, Lundström S, Bottai M, Hellner Gumpert C. Subthreshold and threshold attention deficit hyperactivity disorder symptoms in childhood: psychosocial outcomes in adolescence in boys and girls. Acta Psychiatr Scand 2016;134:533-45. [PMID: 27714770 DOI: 10.1111/acps.12655] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
77 Schuch V, Utsumi DA, Costa TV, Kulikowski LD, Muszkat M. Attention Deficit Hyperactivity Disorder in the Light of the Epigenetic Paradigm. Front Psychiatry 2015;6:126. [PMID: 26441687 DOI: 10.3389/fpsyt.2015.00126] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
78 Edebol H, Helldin L, Norlander T. Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative Participants. Clin Pract Epidemiol Ment Health 2012;8:134-43. [PMID: 23166565 DOI: 10.2174/1745017901208010134] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
79 Jacob L, Haro JM, Koyanagi A. Attention deficit hyperactivity disorder symptoms and disordered eating in the English general population. Int J Eat Disord 2018;51:942-52. [PMID: 30256445 DOI: 10.1002/eat.22934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
80 Nunes EV, Covey LS, Brigham G, Hu MC, Levin FR, Somoza EC, Winhusen TM. Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. J Clin Psychiatry 2013;74:983-90. [PMID: 24229749 DOI: 10.4088/JCP.12m08155] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
81 Hudziak JJ, Achenbach TM, Althoff RR, Pine DS. A dimensional approach to developmental psychopathology. Int J Methods Psychiatr Res 2007;16 Suppl 1:S16-23. [PMID: 17623391 DOI: 10.1002/mpr.217] [Cited by in Crossref: 153] [Cited by in F6Publishing: 138] [Article Influence: 10.2] [Reference Citation Analysis]
82 Chen M, Su T, Chen Y, Hsu J, Huang K, Chang W, Chen T, Bai Y. Higher risk of developing mood disorders among adolescents with comorbidity of attention deficit hyperactivity disorder and disruptive behavior disorder: A nationwide prospective study. Journal of Psychiatric Research 2013;47:1019-23. [DOI: 10.1016/j.jpsychires.2013.04.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
83 Kessler RC, Lane M, Stang PE, Van Brunt DL. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med 2009;39:137-47. [DOI: 10.1017/s0033291708003309] [Cited by in Crossref: 93] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
84 Huang CL, Weng SF, Ho CH. Gender ratios of administrative prevalence and incidence of attention-deficit/hyperactivity disorder (ADHD) across the lifespan: A nationwide population-based study in Taiwan. Psychiatry Res 2016;244:382-7. [PMID: 27525828 DOI: 10.1016/j.psychres.2016.08.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
85 Carton L, Dondaine T, Deheul S, Marquié C, Brigadeau F, Amad A, Devos D, Danel T, Bordet R, Cottencin O, Gautier S, Ménard O. Prescriptions hors AMM supervisées de méthylphénidate dans le TDAH de l’adulte. L'Encéphale 2019;45:74-81. [DOI: 10.1016/j.encep.2018.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Ulke C, Rullmann M, Huang J, Luthardt J, Becker GA, Patt M, Meyer PM, Tiepolt S, Hesse S, Sabri O, Strauß M. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study. Transl Psychiatry 2019;9:301. [PMID: 31732713 DOI: 10.1038/s41398-019-0619-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Moulin F, Chollet A, Ramos-Quiroga JA, Bouvard M, Melchior M, Galéra C. Prevalence and Psychosocial Correlates of ADHD Symptoms in Young Adulthood: A French Population-Based Study. J Atten Disord 2018;22:167-81. [PMID: 28490216 DOI: 10.1177/1087054717706758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
88 Johansen EB, Killeen PR, Russell VA, Tripp G, Wickens JR, Tannock R, Williams J, Sagvolden T. Origins of altered reinforcement effects in ADHD. Behav Brain Funct 2009;5:7. [PMID: 19226460 DOI: 10.1186/1744-9081-5-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 4.7] [Reference Citation Analysis]
89 Marx I, Krause J, Berger C, Häßler F. Dissociable patterns in the control of emotional interference in adults with attention-deficit/hyperactivity disorder (ADHD) and in adults with alcohol dependence. PLoS One 2014;9:e107750. [PMID: 25265290 DOI: 10.1371/journal.pone.0107750] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
90 Ishizuka K, Ishiguro T, Nomura N, Inada T. Depressive mood changes are associated with self-perceptions of ADHD characteristics in adults. Psychiatry Res 2021;300:113893. [PMID: 33799195 DOI: 10.1016/j.psychres.2021.113893] [Reference Citation Analysis]
91 Karalunas SL, Antovich D, Goh PK, Martel MM, Tipsord J, Nousen EK, Nigg JT. Longitudinal network model of the co-development of temperament, executive functioning, and psychopathology symptoms in youth with and without ADHD. Dev Psychopathol 2021;33:1803-20. [DOI: 10.1017/s0954579421000900] [Reference Citation Analysis]
92 Coetzee C, Truter I, Meyer A. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder. Expert Rev Clin Pharmacol 2020;13:1271-80. [PMID: 33040639 DOI: 10.1080/17512433.2020.1835467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, Geels LM, van Beek JH, Bartels M, de Geus EJ, Willemsen G. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One 2010;5:e10621. [PMID: 20485550 DOI: 10.1371/journal.pone.0010621] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
94 Hale AC, Bohnert KM, Spencer RJ, Ganoczy D, Pfeiffer PN. The Prevalence and Incidence of Attention-deficit/Hyperactivity Disorder in the Veterans Health Administration From 2009 to 2016. Med Care 2020;58:273-9. [PMID: 32049948 DOI: 10.1097/MLR.0000000000001287] [Reference Citation Analysis]
95 Jones HA, Eddy LD, Bourchtein E, Parks AM, Green TL, Karjane NW, Svikis DS. Attention-Deficit/Hyperactivity Disorder Symptoms, Depression Risk, and Quality of Life in Black Pregnant Women. Journal of Women's Health 2018;27:1263-70. [DOI: 10.1089/jwh.2017.6547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Schreuer N, Dorot R. Experiences of employed women with attention deficit hyperactive disorder: A phenomenological study. Work 2017;56:429-41. [PMID: 28269805 DOI: 10.3233/WOR-172509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
97 Abbass K, Corbisiero S, Stieglitz RD. Development and psychometric properties of the ADHD-SCL-90-R screening scale for adult ADHD. J Clin Psychol 2021;77:1428-42. [PMID: 33188720 DOI: 10.1002/jclp.23088] [Reference Citation Analysis]
98 Mareva S, Holmes J; CALM team. Transdiagnostic associations across communication, cognitive, and behavioural problems in a developmentally at-risk population: a network approach. BMC Pediatr 2019;19:452. [PMID: 31752809 DOI: 10.1186/s12887-019-1818-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Kessler RC, Haro JM, Heeringa SG, Pennell BE, Ustün TB. The World Health Organization World Mental Health Survey Initiative. Epidemiol Psichiatr Soc 2006;15:161-6. [PMID: 17128617 DOI: 10.1017/s1121189x00004395] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
100 Bogerts B, Peter E, Schiltz K. Aggression, Gewalt, Amok, Stalking. In: Möller H, Laux G, Kapfhammer H, editors. Psychiatrie, Psychosomatik, Psychotherapie. Berlin: Springer Berlin Heidelberg; 2011. pp. 2692-716. [DOI: 10.1007/978-3-642-03637-8_81] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
101 Mastoras SM, Saklofske DH, Schwean VL, Climie EA. Social Support in Children With ADHD: An Exploration of Resilience. J Atten Disord 2018;22:712-23. [PMID: 26515891 DOI: 10.1177/1087054715611491] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Altın M, Altın GE, Semerci B. An online survey of Turkish psychiatrists' attitudes about and experiences of adult attention deficit hyperactivity disorder in clinical practice. Neuropsychiatr Dis Treat 2016;12:2455-61. [PMID: 27785027 DOI: 10.2147/NDT.S110720] [Reference Citation Analysis]
103 Nasser A, Kosheleff AR, Hull JT, Liranso T, Qin P, Busse GD, Fava M, Maletic V, Rubin J, Lopez F. Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder. Int J Clin Pract 2021;75:e14330. [PMID: 33971070 DOI: 10.1111/ijcp.14330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
104 Arnold LE, Hodgkins P, Caci H, Kahle J, Young S. Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review. PLoS One 2015;10:e0116407. [PMID: 25714373 DOI: 10.1371/journal.pone.0116407] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
105 Steinhausen H, Göllner J, Brandeis D, Müller UC, Valko L, Drechsler R. Psychopathology and Personality in Parents of Children With ADHD. J Atten Disord 2013;17:38-46. [DOI: 10.1177/1087054711427562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
106 Pardo A, King TR, Rafla E, Kando JC. Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD. Drug Des Devel Ther 2021;15:2979-85. [PMID: 34262263 DOI: 10.2147/DDDT.S309378] [Reference Citation Analysis]
107 Cederlöf M, Larsson H, Lichtenstein P, Almqvist C, Serlachius E, Ludvigsson JF. Nationwide population-based cohort study of psychiatric disorders in individuals with Ehlers-Danlos syndrome or hypermobility syndrome and their siblings. BMC Psychiatry 2016;16:207. [PMID: 27377649 DOI: 10.1186/s12888-016-0922-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
108 Safren SA, Sprich SE, Cooper-Vince C, Knouse LE, Lerner JA. Life impairments in adults with medication-treated ADHD. J Atten Disord 2010;13:524-31. [PMID: 19395647 DOI: 10.1177/1087054709332460] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
109 Shoham R, Sonuga-Barke E, Yaniv I, Pollak Y. ADHD Is Associated With a Widespread Pattern of Risky Behavior Across Activity Domains. J Atten Disord 2021;25:989-1000. [PMID: 31583930 DOI: 10.1177/1087054719875786] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
110 De Bruyckere K, Bushe C, Bartel C, Berggren L, Kan CC, Dittmann RW. Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database. CNS Drugs 2016;30:541-58. [DOI: 10.1007/s40263-016-0346-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
111 Amani Jabalkandi S, Raisi F, Shahrivar Z, Mohammadi A, Meysamie A, Firoozikhojastefar R, Irani F. A study on sexual functioning in adults with attention-deficit/hyperactivity disorder. Perspect Psychiatr Care 2020;56:642-8. [PMID: 32043624 DOI: 10.1111/ppc.12480] [Reference Citation Analysis]
112 Keyes CLM. The Dual Continua Model: The Foundation of the Sociology of Mental Health and Mental Illness. In: Scheid TL, Wright ER, editors. A Handbook for the Study of Mental Health. Cambridge University Press; 2018. pp. 66-81. [DOI: 10.1017/9781316471289.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
113 Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K. Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI). Neuropsychiatr Dis Treat 2020;16:881-90. [PMID: 32280229 DOI: 10.2147/NDT.S246136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
114 Brownlie EB, Lazare K, Beitchman J. Validating a self-report screen for ADHD in early adulthood using childhood parent and teacher ratings. J Atten Disord 2012;16:467-77. [PMID: 21903889 DOI: 10.1177/1087054711398902] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Koyuncu A, Çelebi F, Ertekin E, Kök BE, Tükel R. Attention deficit and hyperactivity in social anxiety disorder: relationship with trauma history and impulsivity. Atten Defic Hyperact Disord 2016;8:95-100. [PMID: 26797941 DOI: 10.1007/s12402-016-0189-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
116 Newcorn JH, Weiss M, Stein MA. The Complexity of ADHD: Diagnosis and Treatment of the Adult Patient With Comorbidities. CNS Spectr 2007;12:1-16. [DOI: 10.1017/s1092852900026158] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
117 Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res 2007;16:52-65. [PMID: 17623385 DOI: 10.1002/mpr.208] [Cited by in Crossref: 402] [Cited by in F6Publishing: 326] [Article Influence: 26.8] [Reference Citation Analysis]
118 Eme RF. Attention-deficit/hyperactivity disorder and correctional health care. J Correct Health Care 2009;15:5-18. [PMID: 19477807 DOI: 10.1177/1078345808326617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
119 Lyhne CN, Pedersen P, Nielsen CV, Bjerrum MB. Needs for occupational assistance among young adults with ADHD to deal with executive impairments and promote occupational participation - a qualitative study. Nord J Psychiatry 2021;75:362-9. [PMID: 33380255 DOI: 10.1080/08039488.2020.1862911] [Reference Citation Analysis]
120 Johnstone JM, Hatsu I, Tost G, Srikanth P, Eiterman LP, Bruton AM, Ast HK, Robinette LM, Stern MM, Millington EG, Gracious BL, Hughes AJ, Leung BMY, Arnold LE. Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry 2021:S0890-8567(21)00473-1. [PMID: 34303786 DOI: 10.1016/j.jaac.2021.07.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Rucklidge JJ, Johnstone J, Gorman B, Boggis A, Frampton CM. Moderators of treatment response in adults with ADHD treated with a vitamin–mineral supplement. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2014;50:163-71. [DOI: 10.1016/j.pnpbp.2013.12.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
122 Leahy LG. Diagnosis and treatment of ADHD in children vs adults: What nurses should know. Archives of Psychiatric Nursing 2018;32:890-5. [DOI: 10.1016/j.apnu.2018.06.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
123 Attygalle UR, Hewawitharana G, Wijesinghe CJ. Migraine, attention deficit hyperactivity disorder and screen time in children attending a Sri Lankan tertiary care facility: are they associated? BMC Neurol 2020;20:275. [PMID: 32640997 DOI: 10.1186/s12883-020-01855-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Paucke M, Stark T, Exner C, Kallweit C, Hegerl U, Strauß M. [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics]. Nervenarzt 2018;89:1287-93. [PMID: 29916032 DOI: 10.1007/s00115-018-0553-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
125 Biederman J, Fried R, Petty CR, Henin A, Wozniak J, Corkum L, Claudat K, Faraone SV. Examining the Association Between Stimulant Treatment and Cognitive Outcomes Across the Life Cycle of Adults With Attention-Deficit/Hyperactivity Disorder: A Controlled Cross-Sectional Study. Journal of Nervous & Mental Disease 2012;200:69-75. [DOI: 10.1097/nmd.0b013e31823e55ef] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
126 Hawi Z, Tong J, Dark C, Yates H, Johnson B, Bellgrove MA. The role of cadherin genes in five major psychiatric disorders: A literature update. Am J Med Genet B Neuropsychiatr Genet 2018;177:168-80. [PMID: 28921840 DOI: 10.1002/ajmg.b.32592] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
127 Bolden LB, Griffis JC, Pati S, Szaflarski JP. Cortical excitability and neuropsychological functioning in healthy adults. Neuropsychologia 2017;102:190-6. [PMID: 28648572 DOI: 10.1016/j.neuropsychologia.2017.06.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
128 Katzman MA, Bilkey TS, Chokka PR, Fallu A, Klassen LJ. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017;17:302. [PMID: 28830387 DOI: 10.1186/s12888-017-1463-3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 84] [Article Influence: 23.6] [Reference Citation Analysis]
129 Zou H, Yang J. Temporal Variability-Based Functional Brain Lateralization Study in ADHD. J Atten Disord 2021;25:839-47. [PMID: 31268386 DOI: 10.1177/1087054719859074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
130 Rucklidge JJ. Gender differences in attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2010;33:357-73. [PMID: 20385342 DOI: 10.1016/j.psc.2010.01.006] [Cited by in Crossref: 230] [Cited by in F6Publishing: 215] [Article Influence: 19.2] [Reference Citation Analysis]
131 Dan O, Raz S. The Relationships Among ADHD, Self-Esteem, and Test Anxiety in Young Adults. J Atten Disord 2015;19:231-9. [DOI: 10.1177/1087054712454571] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
132 Wu SH, Wang K, Chen Y, Wang WQ, Wang F, Montgomery W, Treuer T. Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder. Asia Pac Psychiatry 2017;9. [PMID: 26663807 DOI: 10.1111/appy.12231] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Heo S, Kim JH, Joung YS, Lee WI, Kim JJ, Sohn SH, Chang SA. Clinical Utility of the Korean Version of the WHO Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale Screener. Psychiatry Investig 2018;15:325-9. [PMID: 29486543 DOI: 10.30773/pi.2017.07.10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
134 Saboya E, Saraiva D, Palmini A, Lima P, Coutinho G. Disfunção executiva como uma medida de funcionalidade em adultos com TDAH. J bras psiquiatr 2007;56:30-3. [DOI: 10.1590/s0047-20852007000500007] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
135 Román-Ithier JC, González RA, Vélez-Pastrana MC, González-Tejera GM, Albizu-García CE. Attention deficit hyperactivity disorder symptoms, type of offending and recidivism in a prison population: The role of substance dependence. Crim Behav Ment Health 2017;27:443-56. [PMID: 27455899 DOI: 10.1002/cbm.2009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
136 Modesto-Lowe V, Farahmand P, Chaplin M, Sarro L. Does mindfulness meditation improve attention in attention deficit hyperactivity disorder? World J Psychiatr 2015; 5(4): 397-403 [PMID: 26740931 DOI: 10.5498/wjp.v5.i4.397] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
137 Mahadevan J, Kandasamy A, Benegal V. Situating adult attention-deficit/hyperactivity disorder in the externalizing spectrum: Etiological, diagnostic, and treatment considerations. Indian J Psychiatry 2019;61:3-12. [PMID: 30745648 DOI: 10.4103/psychiatry.IndianJPsychiatry_549_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Baumgaertel A, Blaskey L, Antia SX. Disruptive Behavior Disorders. In: Fatemi SH, Clayton PJ, editors. The Medical Basis of Psychiatry. Totowa: Humana Press; 2008. pp. 301-33. [DOI: 10.1007/978-1-59745-252-6_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Schiff R, Ravid D, Gur A. Morpho-Syntactic Load in Judging Adjective Plural Agreement: Comparing Adults With and Without ADHD. Communication Disorders Quarterly 2015;36:79-89. [DOI: 10.1177/1525740114537519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Zhang X, Newport G, Callicott R, Liu S, Thompson J, Berridge M, Apana S, Slikker W, Wang C, Paule M. MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates. Neurotoxicology and Teratology 2016;56:68-74. [DOI: 10.1016/j.ntt.2016.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
141 Groeneveld KM, Mennenga AM, Heidelberg RC, Martin RE, Tittle RK, Meeuwsen KD, Walker LA, White EK. Z-Score Neurofeedback and Heart Rate Variability Training for Adults and Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Retrospective Study. Appl Psychophysiol Biofeedback 2019;44:291-308. [PMID: 31119405 DOI: 10.1007/s10484-019-09439-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
142 Olfson M, Wang S, Wall M, Marcus SC, Blanco C. Trends in Serious Psychological Distress and Outpatient Mental Health Care of US Adults. JAMA Psychiatry 2019;76:152-61. [PMID: 30484838 DOI: 10.1001/jamapsychiatry.2018.3550] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
143 Wietecha L, Young J, Ruff D, Dunn D, Findling RL, Saylor K. Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning. Clin Neuropharmacol 2012;35:125-33. [PMID: 22561876 DOI: 10.1097/WNF.0b013e3182560315] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
144 Roh S, Park E, Shim M, Lee S. EEG beta and low gamma power correlates with inattention in patients with major depressive disorder. Journal of Affective Disorders 2016;204:124-30. [DOI: 10.1016/j.jad.2016.06.033] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
145 Sánchez EY, Velarde S, Britton GB. Estimated prevalence of attention-deficit/hyperactivity disorder in a sample of Panamanian school-aged children. Child Psychiatry Hum Dev 2011;42:243-55. [PMID: 21127963 DOI: 10.1007/s10578-010-0213-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
146 Ahmad SI, Meza JI, Posserud MB, Brevik EJ, Hinshaw SP, Lundervold AJ. Attention-Deficit/Hyperactivity Disorder Symptom Dimensions Differentially Predict Adolescent Peer Problems: Findings From Two Longitudinal Studies. Front Psychol 2020;11:609789. [PMID: 33584444 DOI: 10.3389/fpsyg.2020.609789] [Reference Citation Analysis]
147 Montano CB, Weisler R. Distinguishing symptoms of ADHD from other psychiatric disorders in the adult primary care setting. Postgrad Med 2011;123:88-98. [PMID: 21566419 DOI: 10.3810/pgm.2011.05.2287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
148 Young S, Hollingdale J, Absoud M, Bolton P, Branney P, Colley W, Craze E, Dave M, Deeley Q, Farrag E, Gudjonsson G, Hill P, Liang HL, Murphy C, Mackintosh P, Murin M, O'Regan F, Ougrin D, Rios P, Stover N, Taylor E, Woodhouse E. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. BMC Med 2020;18:146. [PMID: 32448170 DOI: 10.1186/s12916-020-01585-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
149 Lee KC, Kim E, Kim J, Malcolm B, Kuo GM, Bird A, Feifel D. Development of an innovative adult attention-deficit hyperactivity disorder clinic. Ment Health Clin 2020;10:296-300. [PMID: 33062556 DOI: 10.9740/mhc.2020.09.296] [Reference Citation Analysis]
150 Sultan RS, Liu SM, Hacker KA, Olfson M. Adolescents With Attention-Deficit/Hyperactivity Disorder: Adverse Behaviors and Comorbidity. J Adolesc Health 2021;68:284-91. [PMID: 33541601 DOI: 10.1016/j.jadohealth.2020.09.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
151 Wang Z, Kosheleff AR, Adeojo LW, Odebo O, Adewole T, Qin P, Maletic V, Schwabe S, Nasser A. Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN-812 (Viloxazine Extended-Release) Pharmacokinetics in Healthy Adults. Clin Pharmacol Drug Dev 2021. [PMID: 33943033 DOI: 10.1002/cpdd.948] [Reference Citation Analysis]
152 Advokat C, Lane SM, Luo C. College Students With and Without ADHD: Comparison of Self-Report of Medication Usage, Study Habits, and Academic Achievement. J Atten Disord 2011;15:656-66. [DOI: 10.1177/1087054710371168] [Cited by in Crossref: 85] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
153 Watts SJ. ADHD Symptomatology and Criminal Behavior During Adolescence: Exploring the Mediating Role of School Factors. Int J Offender Ther Comp Criminol 2018;62:3-23. [DOI: 10.1177/0306624x16639970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Chen C, Dai S, Shi L, Shen Y, Ou J. Associations Between Attention Deficit/Hyperactivity Disorder and Internet Gaming Disorder Symptoms Mediated by Depressive Symptoms and Hopelessness Among College Students. Neuropsychiatr Dis Treat 2021;17:2775-82. [PMID: 34465993 DOI: 10.2147/NDT.S325323] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Lee KM, Olenchak FR. Individuals with a gifted/attention deficit/hyperactivity disorder diagnosis: Identification, performance, outcomes, and interventions. Gifted Education International 2015;31:185-99. [DOI: 10.1177/0261429414530712] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
156 Lu AT, Ogdie MN, Järvelin MR, Moilanen IK, Loo SK, McCracken JT, McGough JJ, Yang MH, Peltonen L, Nelson SF, Cantor RM, Smalley SL. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1488-94. [PMID: 18213623 DOI: 10.1002/ajmg.b.30693] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
157 Yager J. Can Trans-Syndromal Prototypes ("Types") Improve Depiction of Complex Psychiatric Cases?: An Alternative Way to Consider Concordant Comorbid Psychiatric Disorders and Their Contexts as Coherent Units for Research, Assessment, and Treatment Planning. J Nerv Ment Dis 2021;209:1-8. [PMID: 33141784 DOI: 10.1097/NMD.0000000000001261] [Reference Citation Analysis]
158 Skirrow C, McLoughlin G, Banaschewski T, Brandeis D, Kuntsi J, Asherson P. Normalisation of frontal theta activity following methylphenidate treatment in adult attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol 2015;25:85-94. [PMID: 25435084 DOI: 10.1016/j.euroneuro.2014.09.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
159 Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L; 304 Study Group. Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. CNS spectr 2009;14:573-86. [DOI: 10.1017/s1092852900024056] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 7.9] [Reference Citation Analysis]
160 Knouse LE, Zvorsky I, Safren SA. Depression in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): The Mediating Role of Cognitive-Behavioral Factors. Cognit Ther Res 2013;37:1220-32. [PMID: 26089578 DOI: 10.1007/s10608-013-9569-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
161 Gerhard T, Winterstein AG, Olfson M, Huang C, Saidi A, Crystal S. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidemiol Drug Saf 2010;19:457-64. [PMID: 20232490 DOI: 10.1002/pds.1931] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
162 Koemans RG, van Vroenhoven S, Karreman A, Bekker MH. Attachment and autonomy problems in adults with ADHD. J Atten Disord 2015;19:435-46. [PMID: 22956713 DOI: 10.1177/1087054712453170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
163 Mao AR, Findling RL. Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care. Postgrad Med 2014;126:42-51. [PMID: 25295649 DOI: 10.3810/pgm.2014.09.2799] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
164 Bleck J, Debate R, Levin BL, Baldwin J. Underlying Mechanisms and Trajectory of Comorbid ADHD and Eating Disorders: Proposing an Innovative Systems Framework for Informing Research. Int J Ment Health Addiction 2016;14:449-58. [DOI: 10.1007/s11469-015-9593-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
165 Goldenson NI, Pang RD, Leventhal AM. Associations between ADHD symptoms and smoking outcome expectancies in a non-clinical sample of daily cigarette smokers. Am J Addict 2016;25:152-9. [PMID: 26871681 DOI: 10.1111/ajad.12343] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
166 Helfer B, Cooper RE, Bozhilova N, Maltezos S, Kuntsi J, Asherson P. The effects of emotional lability, mind wandering and sleep quality on ADHD symptom severity in adults with ADHD. Eur psychiatr 2019;55:45-51. [DOI: 10.1016/j.eurpsy.2018.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
167 Marchant BK, Reimherr FW, Robison RJ, Olsen JL, Kondo DG. Methylphenidate Transdermal System in Adult ADHD and Impact on Emotional and Oppositional Symptoms. J Atten Disord 2011;15:295-304. [DOI: 10.1177/1087054710365986] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
168 Redelmeier DA, Chan WK, Lu H. Road trauma in teenage male youth with childhood disruptive behavior disorders: a population based analysis. PLoS Med 2010;7:e1000369. [PMID: 21125017 DOI: 10.1371/journal.pmed.1000369] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
169 Mörtberg E, Tilfors K, Bejerot S. Screening for ADHD in an Adult Social Phobia Sample. J Atten Disord 2012;16:645-9. [DOI: 10.1177/1087054711423623] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
170 Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, Biederman J. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011;50:543-53. [PMID: 21621138 DOI: 10.1016/j.jaac.2011.01.021] [Cited by in Crossref: 160] [Cited by in F6Publishing: 122] [Article Influence: 14.5] [Reference Citation Analysis]
171 Manderino L, Gunstad J. Collegiate Student Athletes With History of ADHD or Academic Difficulties Are More Likely to Produce an Invalid Protocol on Baseline ImPACT Testing. Clin J Sport Med 2018;28:111-6. [PMID: 28731886 DOI: 10.1097/JSM.0000000000000433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
172 Kirkpatrick MG, Goldenson NI, Kapadia N, Kahler CW, de Wit H, Swift RM, McGeary JE, Sussman S, Leventhal AM. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl) 2016;233:89-97. [PMID: 26429791 DOI: 10.1007/s00213-015-4091-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
173 London AS, Landes SD. Attention Deficit Hyperactivity Disorder and adult mortality. Prev Med 2016;90:8-10. [PMID: 27343403 DOI: 10.1016/j.ypmed.2016.06.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
174 Besson M, Forget B. Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective. Front Psychiatry 2016;7:160. [PMID: 27708591 DOI: 10.3389/fpsyt.2016.00160] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
175 McRae-Clark AL, Brady KT, Hartwell KJ, White K, Carter RE. Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial. J Atten Disord 2011;15:539-44. [PMID: 20538968 DOI: 10.1177/1087054710371171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
176 Fried R, Petty C, Faraone SV, Hyder LL, Day H, Biederman J. Is ADHD a Risk Factor for High School Dropout? A Controlled Study. J Atten Disord 2016;20:383-9. [DOI: 10.1177/1087054712473180] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
177 Skoglund C, Brandt L, Almqvist C, DʼOnofrio BM, Konstenius M, Franck J, Larsson H. Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders. J Clin Psychopharmacol 2016;36:222-8. [PMID: 27043119 DOI: 10.1097/JCP.0000000000000501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
178 Huggins SP, Rooney ME, Chronis-Tuscano A. Risky sexual behavior among college students With ADHD: is the mother-child relationship protective? J Atten Disord 2015;19:240-50. [PMID: 23048048 DOI: 10.1177/1087054712459560] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
179 Ben Shalom D, Ronel Z, Faran Y, Meiri G, Gabis L, Kerns KA. A Double Dissociation Between Inattentive and Impulsive Traits, on Tasks of Visual Processing and Emotion Regulation. J Atten Disord 2017;21:543-53. [PMID: 24327277 DOI: 10.1177/1087054713510351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
180 Rush BR, Dennis ML, Scott CK, Castel S, Funk RR. The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery. Eval Rev 2008;32:7-38. [PMID: 18198169 DOI: 10.1177/0193841X07307532] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
181 Biederman J, Petty CR, Evans M, Small J, Faraone SV. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res 2010;177:299-304. [PMID: 20452063 DOI: 10.1016/j.psychres.2009.12.010] [Cited by in Crossref: 263] [Cited by in F6Publishing: 218] [Article Influence: 21.9] [Reference Citation Analysis]
182 McCabe SE, West BT. Medical and nonmedical use of prescription stimulants: results from a national multicohort study. J Am Acad Child Adolesc Psychiatry 2013;52:1272-80. [PMID: 24290460 DOI: 10.1016/j.jaac.2013.09.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
183 Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010;167:958-68. [PMID: 20231319 DOI: 10.1176/appi.ajp.2009.09081123] [Cited by in Crossref: 232] [Cited by in F6Publishing: 164] [Article Influence: 19.3] [Reference Citation Analysis]
184 Salomone S, Fleming GR, Bramham J, O'Connell RG, Robertson IH. Neuropsychological Deficits in Adult ADHD: Evidence for Differential Attentional Impairments, Deficient Executive Functions, and High Self-Reported Functional Impairments. J Atten Disord 2020;24:1413-24. [PMID: 26769747 DOI: 10.1177/1087054715623045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
185 Dakwar E, Mahony A, Pavlicova M, Glass A, Brooks D, Mariani JJ, Grabowski J, Levin FR. The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. J Clin Psychiatry 2012;73:e1372-8. [PMID: 23218166 DOI: 10.4088/JCP.12m07895] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
186 Donnelly CL. History and pathophysiology of ADHD. CNS Spectr 2006;11:4-6. [PMID: 17008823 DOI: 10.1017/s109285290002575x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
187 Sarkis E. Addressing attention-deficit/hyperactivity disorder in the workplace. Postgrad Med 2014;126:25-30. [PMID: 25295647 DOI: 10.3810/pgm.2014.09.2797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
188 Sônego M, Meller M, Massuti R, Campani F, Amaro J, Barbosa C, Rohde LA. Exploring the association between attention-deficit/hyperactivity disorder and entrepreneurship. Braz J Psychiatry 2021;43:174-80. [PMID: 32555982 DOI: 10.1590/1516-4446-2020-0898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Welkie J, Babinski DE, Neely KA. Sex and Emotion Regulation Difficulties Contribute to Depression in Young Adults With Attention-Deficit/Hyperactivity Disorder. Psychol Rep 2021;124:596-610. [PMID: 32316842 DOI: 10.1177/0033294120918803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 French WP. Assessment and treatment of attention-deficit/hyperactivity disorder: part 1. Pediatr Ann 2015;44:114-20. [PMID: 25806728 DOI: 10.3928/00904481-20150313-13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
191 Weiner L, Perroud N, Weibel S. Attention Deficit Hyperactivity Disorder And Borderline Personality Disorder In Adults: A Review Of Their Links And Risks. Neuropsychiatr Dis Treat 2019;15:3115-29. [PMID: 31806978 DOI: 10.2147/NDT.S192871] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
192 Lee KS, Osborne RE, Hayes KA, Simoes RA. The Effects of Pacing on the Academic Testing Performance of College Students with Adhd: A Mixed Methods Study. Journal of Educational Computing Research 2008;39:123-41. [DOI: 10.2190/ec.39.2.b] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
193 Rohlf H, Jucksch V, Gawrilow C, Huss M, Hein J, Lehmkuhl U, Salbach-Andrae H. Set shifting and working memory in adults with attention-deficit/hyperactivity disorder. J Neural Transm (Vienna) 2012;119:95-106. [PMID: 21626411 DOI: 10.1007/s00702-011-0660-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
194 Morkem R, Handelman K, Queenan JA, Birtwhistle R, Barber D. Validation of an EMR algorithm to measure the prevalence of ADHD in the Canadian Primary Care Sentinel Surveillance Network (CPCSSN). BMC Med Inform Decis Mak 2020;20:166. [PMID: 32690025 DOI: 10.1186/s12911-020-01182-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Knouse LE, Barkley RA, Murphy KR. Does executive functioning (EF) predict depression in clinic-referred adults? EF tests vs. rating scales. J Affect Disord 2013;145:270-5. [PMID: 22858220 DOI: 10.1016/j.jad.2012.05.064] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
196 Bouchatta O, Manouze H, Bouali-Benazzouz R, Kerekes N, Ba-M'hamed S, Fossat P, Landry M, Bennis M. Neonatal 6-OHDA lesion model in mouse induces Attention-Deficit/ Hyperactivity Disorder (ADHD)-like behaviour. Sci Rep 2018;8:15349. [PMID: 30337626 DOI: 10.1038/s41598-018-33778-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
197 Adams Z, Adams T, Stauffacher K, Mandel H, Wang Z. The Effects of Inattentiveness and Hyperactivity on Posttraumatic Stress Symptoms: Does a Diagnosis of Posttraumatic Stress Disorder Matter? J Atten Disord 2020;24:1246-54. [PMID: 25882836 DOI: 10.1177/1087054715580846] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
198 Peskin VA, Ordóñez A, Mackin RS, Delucchi K, Monge S, McGough JJ, Chavira DA, Berrocal M, Cheung E, Fournier E, Badner JA, Herrera LD, Mathews CA. Neuropsychological and dimensional behavioral trait profiles in Costa Rican ADHD sib pairs: Potential intermediate phenotypes for genetic studies. Am J Med Genet B Neuropsychiatr Genet 2015;168B:247-57. [PMID: 25832558 DOI: 10.1002/ajmg.b.32305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
199 Ramsay JR. Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2007;9:427-33. [DOI: 10.1007/s11920-007-0056-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
200 Romanos M, Schwenck C, Walitza S. Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Kindes- und Jugendalter. Nervenarzt 2008;79:782-90. [DOI: 10.1007/s00115-008-2511-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
201 van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA, Levin FR; IASP Research Group. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend 2013;132:587-96. [PMID: 23660242 DOI: 10.1016/j.drugalcdep.2013.04.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
202 Sanefuji M, Craig M, Parlatini V, Mehta MA, Murphy DG, Catani M, Cerliani L, Thiebaut de Schotten M. Double-dissociation between the mechanism leading to impulsivity and inattention in Attention Deficit Hyperactivity Disorder: A resting-state functional connectivity study. Cortex 2017;86:290-302. [DOI: 10.1016/j.cortex.2016.06.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 5.4] [Reference Citation Analysis]
203 Scott DA, Gignac M, Kronfli RN, Ocana A, Lorberg GW. Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities. J Correct Health Care 2016;22:46-61. [PMID: 26672119 DOI: 10.1177/1078345815618392] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
204 Nyström A, Petersson K, Janlöv AC. Being Different but Striving to Seem Normal: The Lived Experiences of People Aged 50+ with ADHD. Issues Ment Health Nurs 2020;41:476-85. [PMID: 32267788 DOI: 10.1080/01612840.2019.1695029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Biskup CS, Helmbold K, Baurmann D, Klasen M, Gaber TJ, Bubenzer-Busch S, Königschulte W, Fink GR, Zepf FD. Resting state default mode network connectivity in children and adolescents with ADHD after acute tryptophan depletion. Acta Psychiatr Scand 2016;134:161-71. [PMID: 27145324 DOI: 10.1111/acps.12573] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
206 Retz-junginger P, Sobanski E, Alm B, Retz W, Rösler M. Alters- und geschlechtsspezifische Besonderheiten der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Nervenarzt 2008;79:809-19. [DOI: 10.1007/s00115-008-2509-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
207 Matthies S, Philipsen A, Svaldi J. Risky decision making in adults with ADHD. Journal of Behavior Therapy and Experimental Psychiatry 2012;43:938-46. [DOI: 10.1016/j.jbtep.2012.02.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
208 Koyuncu A, Ertekin E, Yüksel Ç, Aslantaş Ertekin B, Çelebi F, Binbay Z, Tükel R. Predominantly Inattentive Type of ADHD is Associated With Social Anxiety Disorder. J Atten Disord 2015;19:856-64. [PMID: 24813648 DOI: 10.1177/1087054714533193] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
209 Engelhardt PE, Ferreira F, Nigg JT. Priming sentence production in adolescents and adults with attention-deficit/hyper-activity disorder. J Abnorm Child Psychol 2009;37:995-1006. [PMID: 19421852 DOI: 10.1007/s10802-009-9323-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
210 Van Hout MC, Foley M. Attention-deficit hyperactivity disorder (ADHD) in adults attending addiction treatment in Ireland: preliminary international ADHD in substance-use disorders prevalence study (IASP) results. Ir J Psychol Med 2013;30:171-7. [PMID: 30189493 DOI: 10.1017/ipm.2013.8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
211 Reyes MM, Schneekloth TD, Hitschfeld MJ, Karpyak VM. Impact of Sex and ADHD Status on Psychiatric Comorbidity in Treatment-Seeking Alcoholics. J Atten Disord 2019;23:1505-13. [PMID: 30394819 DOI: 10.1177/1087054718807997] [Reference Citation Analysis]
212 Zayats T, Athanasiu L, Sonderby I, Djurovic S, Westlye LT, Tamnes CK, Fladby T, Aase H, Zeiner P, Reichborn-Kjennerud T, Knappskog PM, Knudsen GP, Andreassen OA, Johansson S, Haavik J. Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PLoS One 2015;10:e0122501. [PMID: 25875332 DOI: 10.1371/journal.pone.0122501] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
213 Kutzbach B, Summers CG, Holleschau AM, King RA, MacDonald JT. The prevalence of attention-deficit/hyperactivity disorder among persons with albinism. J Child Neurol 2007;22:1342-7. [PMID: 18174549 DOI: 10.1177/0883073807307078] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
214 Seidman LJ, Biederman J, Liang L, Valera EM, Monuteaux MC, Brown A, Kaiser J, Spencer T, Faraone SV, Makris N. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol Psychiatry 2011;69:857-66. [PMID: 21183160 DOI: 10.1016/j.biopsych.2010.09.053] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 8.6] [Reference Citation Analysis]
215 Waite R. Women and attention deficit disorders: a great burden overlooked. J Am Acad Nurse Pract 2007;19:116-25. [PMID: 17341278 DOI: 10.1111/j.1745-7599.2006.00203.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
216 Goodman DW. Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies. Ther Clin Risk Manag 2013;9:121-30. [PMID: 23576871 DOI: 10.2147/TCRM.S30762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
217 Planton M, Lemesle B, Cousineau M, Carlier J, Milongo-Rigal E, Carle-Toulemonde G, Salles J, Pariente J. The role of neuropsychological assessment in adults with attention deficit/hyperactivity disorders. Rev Neurol (Paris) 2021;177:341-8. [PMID: 33618892 DOI: 10.1016/j.neurol.2021.01.006] [Reference Citation Analysis]
218 Çelebi F, Ünal D. Self esteem and clinical features in a clinical sample of children with ADHD and social anxiety disorder. Nord J Psychiatry 2021;75:286-91. [PMID: 33475025 DOI: 10.1080/08039488.2020.1850857] [Reference Citation Analysis]
219 Shah P, Buschkuehl M, Jaeggi S, Jonides J. Cognitive training for ADHD: The importance of individual differences. Journal of Applied Research in Memory and Cognition 2012;1:204-5. [DOI: 10.1016/j.jarmac.2012.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
220 Königs A, Kiliaan AJ. Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment. Neuropsychiatr Dis Treat 2016;12:1869-82. [PMID: 27555775 DOI: 10.2147/NDT.S68652] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
221 Dan O, Haimov I, Asraf K, Nachum K, Cohen A. The Effect of Sleep Deprivation on Recognition of Ambiguous Emotional Facial Expressions in Individuals With ADHD. J Atten Disord 2020;24:565-75. [PMID: 29973106 DOI: 10.1177/1087054718785473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Chen MH, Chen YS, Hsu JW, Huang KL, Li CT, Lin WC, Chang WH, Chen TJ, Pan TL, Su TP, Bai YM. Comorbidity of ADHD and subsequent bipolar disorder among adolescents and young adults with major depression: a nationwide longitudinal study. Bipolar Disord 2015;17:315-22. [PMID: 25295997 DOI: 10.1111/bdi.12266] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
223 Friedrichs B, Igl W, Larsson H, Larsson JO. Coexisting psychiatric problems and stressful life events in adults with symptoms of ADHD--a large Swedish population-based study of twins. J Atten Disord 2012;16:13-22. [PMID: 20686099 DOI: 10.1177/1087054710376909] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
224 Chung W, Jiang SF, Paksarian D, Nikolaidis A, Castellanos FX, Merikangas KR, Milham MP. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups. JAMA Netw Open 2019;2:e1914344. [PMID: 31675080 DOI: 10.1001/jamanetworkopen.2019.14344] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
225 Novis-Deutsch N, Dayan H, Pollak Y, Khoury-Kassabri M. Religiosity as a moderator of ADHD-related antisocial behaviour and emotional distress among secular, religious and Ultra-Orthodox Jews in Israel. Int J Soc Psychiatry 2021;:207640211005501. [PMID: 33855872 DOI: 10.1177/00207640211005501] [Reference Citation Analysis]
226 Bron TI, Bijlenga D, Verduijn J, Penninx BW, Beekman AT, Kooij JS. Prevalence of ADHD symptoms across clinical stages of major depressive disorder. Journal of Affective Disorders 2016;197:29-35. [DOI: 10.1016/j.jad.2016.02.053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
227 Nazar BP, Pinna CMDS, Coutinho G, Segenreich D, Duchesne M, Appolinario JC, Mattos P. Review of literature of attention-deficit/hyperactivity disorder with comorbid eating disorders. Rev Bras Psiquiatr 2008;30:384-9. [DOI: 10.1590/s1516-44462008000400014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
228 Buitelaar JK, Kooij JS, Ramos-quiroga JA, Dejonckheere J, Casas M, van Oene JC, Schäuble B, Trott G. Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011;35:554-60. [DOI: 10.1016/j.pnpbp.2010.12.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
229 Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 2008;162:916-21. [PMID: 18838643 DOI: 10.1001/archpedi.162.10.916] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 5.5] [Reference Citation Analysis]
230 Breyer JL, Lee S, Winters KC, August GJ, Realmuto GM. A longitudinal study of childhood ADHD and substance dependence disorders in early adulthood. Psychol Addict Behav 2014;28:238-46. [PMID: 24731117 DOI: 10.1037/a0035664] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
231 Mcintyre R. Bipolar Disorder and ADHD: Clinical Concerns. CNS Spectr 2009;14:8-9. [DOI: 10.1017/s1092852900024822] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
232 Ortega F, Barros D, Caliman L, Itaborahy C, Junqueira L, Ferreira CP. A ritalina no Brasil: produções, discursos e práticas. Interface (Botucatu) 2010;14:499-512. [DOI: 10.1590/s1414-32832010005000003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
233 Nigg JT, Sibley MH, Thapar A, Karalunas SL. Development of ADHD: Etiology, Heterogeneity, and Early Life Course. Annu Rev Dev Psychol 2020;2:559-83. [PMID: 34368774 DOI: 10.1146/annurev-devpsych-060320-093413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
234 Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Kotarski M, Spencer T. A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 2010;30:549-53. [DOI: 10.1097/jcp.0b013e3181ee84a7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
235 Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 2005;57:1293-300. [PMID: 15950001 DOI: 10.1016/j.biopsych.2005.03.036] [Cited by in Crossref: 118] [Cited by in F6Publishing: 104] [Article Influence: 6.9] [Reference Citation Analysis]
236 Purper-ouakil D, Porfirio M, Le Strat Y, Falissard B, Gorwood P, Masi G. What do childhood attention deficit/hyperactivity symptoms in depressed adults tell us about the bipolar spectrum? Psychiatry Research 2017;249:244-51. [DOI: 10.1016/j.psychres.2016.12.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
237 Vanicek T, Spies M, Rami-Mark C, Savli M, Höflich A, Kranz GS, Hahn A, Kutzelnigg A, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Volkow ND, Kasper S, Lanzenberger R. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography. JAMA Psychiatry 2014;71:1340-9. [PMID: 25338091 DOI: 10.1001/jamapsychiatry.2014.1226] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
238 Faison SL, Fry N, Adewole T, Odebo O, Schwabe S, Wang Z, Maletic V, Nasser A. Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults. Clin Drug Investig 2021;41:149-59. [PMID: 33368026 DOI: 10.1007/s40261-020-00992-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
239 McDonald DC, Jalbert SK. Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008. Psychiatr Serv. 2013;64:1079-1086. [PMID: 23912601 DOI: 10.1176/appi.ps.004442012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
240 El Malhany N, Gulisano M, Rizzo R, Curatolo P. Tourette syndrome and comorbid ADHD: causes and consequences. Eur J Pediatr 2015;174:279-88. [PMID: 25224657 DOI: 10.1007/s00431-014-2417-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
241 Adler LD, Nierenberg AA. Review of Medication Adherence in Children and Adults with ADHD. Postgraduate Medicine 2015;122:184-91. [DOI: 10.3810/pgm.2010.01.2112] [Cited by in Crossref: 164] [Cited by in F6Publishing: 133] [Article Influence: 23.4] [Reference Citation Analysis]
242 Hasslinger J, D'Agostini Souto M, Folkesson Hellstadius L, Bölte S. Neurofeedback in ADHD: A qualitative study of strategy use in slow cortical potential training. PLoS One 2020;15:e0233343. [PMID: 32497051 DOI: 10.1371/journal.pone.0233343] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Wang BQ, Yao NQ, Zhou X, Liu J, Lv ZT. The association between attention deficit/hyperactivity disorder and internet addiction: a systematic review and meta-analysis. BMC Psychiatry 2017;17:260. [PMID: 28724403 DOI: 10.1186/s12888-017-1408-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 9.6] [Reference Citation Analysis]
244 Salavera C, Antoñanzas JL, Bustamante JC, Carrón J, Usán P, Teruel P, Bericat C, Monteagudo L, Larrosa S, Tricás JM, Lucha O, Noé R, Jarie L, Cerra R. Comorbidity of attention deficit hyperactivity disorder with personality disorders in homeless people. BMC Res Notes 2014;7:916. [PMID: 25516377 DOI: 10.1186/1756-0500-7-916] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
245 Shi M, Liu L, Sun X, Wang L. Associations between symptoms of attention-deficit/ hyperactivity disorder and life satisfaction in medical students: the mediating effect of resilience. BMC Med Educ 2018;18:164. [PMID: 30005708 DOI: 10.1186/s12909-018-1261-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
246 Spencer TJ, Adler LA, Meihua Qiao, Saylor KE, Brown TE, Holdnack JA, Schuh KJ, Trzepacz PT, Kelsey DK. Validation of the adult ADHD investigator symptom rating scale (AISRS). J Atten Disord 2010;14:57-68. [PMID: 19794135 DOI: 10.1177/1087054709347435] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
247 Ebel L, Petri S, Krauss JK, Dengler R, de Zwaan M. Lack of an association between attention-deficit/hyperactivity disorder (ADHD) and amyotrophic lateral sclerosis (ALS). J Neurol Sci 2018;385:7-11. [PMID: 29406917 DOI: 10.1016/j.jns.2017.11.042] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
248 Lineweaver TT, Kercood S, Gabor AJ, Cervantes J, Laine A, Baker E. The effect of medication and question wording on self-reported symptoms and their accuracy in young adults with attention-deficit/hyperactivity disorder. Br J Clin Psychol 2021;60:252-69. [PMID: 33393098 DOI: 10.1111/bjc.12276] [Reference Citation Analysis]
249 Schoenfelder EN, Chronis-Tuscano A, Strickland J, Almirall D, Stein MA. Piloting a Sequential, Multiple Assignment, Randomized Trial for Mothers with Attention-Deficit/Hyperactivity Disorder and Their At-Risk Young Children. J Child Adolesc Psychopharmacol 2019;29:256-67. [PMID: 30950637 DOI: 10.1089/cap.2018.0136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Brown TE. ADD/ADHD and impaired executive function in clinical practice. Curr Atten Disord Rep 2009;1:37-41. [DOI: 10.1007/s12618-009-0006-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
251 Vogel SWN, Bijlenga D, Verduijn J, Bron TI, Beekman ATF, Kooij JJS, Penninx BWJH. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers. Psychoneuroendocrinology 2017;79:31-9. [PMID: 28249186 DOI: 10.1016/j.psyneuen.2017.02.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
252 Holden SE, Jenkins-Jones S, Poole CD, Morgan CL, Coghill D, Currie CJ. The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health 2013;7:34. [PMID: 24119376 DOI: 10.1186/1753-2000-7-34] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
253 Calamia M, Hill BD, Musso MW, Pella RD, Gouvier WD. Factor structure and clinical correlates of the 61-item Wender Utah Rating Scale (WURS). Atten Defic Hyperact Disord 2018;10:177-88. [PMID: 29427262 DOI: 10.1007/s12402-018-0251-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
254 Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008;33:1199-207. [PMID: 18558465 DOI: 10.1016/j.addbeh.2008.05.003] [Cited by in Crossref: 121] [Cited by in F6Publishing: 96] [Article Influence: 8.6] [Reference Citation Analysis]
255 Fried R, DiSalvo M, Kelberman C, Biederman J. Can the CANTAB identify adults with attention-deficit/hyperactivity disorder? A controlled study. Appl Neuropsychol Adult 2021;28:318-27. [PMID: 31303053 DOI: 10.1080/23279095.2019.1633328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
256 Biederman J, Fitzgerald M, Spencer TJ, Adler LA, Abrams J, Biederman I, Faraone SV. Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD. J Atten Disord 2020;24:420-4. [PMID: 29804496 DOI: 10.1177/1087054718776425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Bauer J, Werner A, Kohl W, Kugel H, Shushakova A, Pedersen A, Ohrmann P. Hyperactivity and impulsivity in adult attention-deficit/hyperactivity disorder is related to glutamatergic dysfunction in the anterior cingulate cortex. World J Biol Psychiatry. 2016;1-9. [PMID: 27973969 DOI: 10.1080/15622975.2016.1262060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
258 Ramos-quiroga JA, Corominas M, Castells X, Bosch R, Casas M. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics 2014;9:1121-31. [DOI: 10.1586/ern.09.65] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
259 Barkley RA, Brown TE. Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr 2008;13:977-84. [PMID: 19037178 DOI: 10.1017/s1092852900014036] [Cited by in Crossref: 79] [Cited by in F6Publishing: 29] [Article Influence: 6.1] [Reference Citation Analysis]
260 Turel O, Bechara A. Social Networking Site Use While Driving: ADHD and the Mediating Roles of Stress, Self-Esteem and Craving. Front Psychol 2016;7:455. [PMID: 27065923 DOI: 10.3389/fpsyg.2016.00455] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
261 Knouse LE, Mitchell JT. Incautiously Optimistic: Positively-Valenced Cognitive Avoidance in Adult ADHD. Cogn Behav Pract 2015;22:192-202. [PMID: 25908901 DOI: 10.1016/j.cbpra.2014.06.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
262 Manor I, Newcorn JH, Faraone SV, Adler LA. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder. Postgrad Med. 2013;125:181-190. [PMID: 23933905 DOI: 10.3810/pgm.2013.07.2689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
263 Mason MJ, Walker LR, Wine LA, Knoper TS, Tercyak KP. Child and Adolescent Tobacco and Substance Use within the Context of ADHD: Implications for Prevention and Treatment. J Clin Psychol Med Settings 2007;14:227-37. [DOI: 10.1007/s10880-007-9078-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
264 Biederman J, Mick E, Spencer T, Surman C, Faraone SV. Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. CNS Neurosci Ther 2012;18:126-32. [PMID: 22070421 DOI: 10.1111/j.1755-5949.2010.00233.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
265 Salomone S, Fleming GR, Shanahan JM, Castorina M, Bramham J, O'Connell RG, Robertson IH. The effects of a Self-Alert Training (SAT) program in adults with ADHD. Front Hum Neurosci 2015;9:45. [PMID: 25713523 DOI: 10.3389/fnhum.2015.00045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
266 Biederman J, Mick EO, Surman C, Doyle R, Hammerness P, Michel E, Martin J, Spencer TJ. Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. BMC Psychiatry 2007;7:49. [PMID: 17868455 DOI: 10.1186/1471-244X-7-49] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
267 Emser TS, Johnston BA, Steele JD, Kooij S, Thorell L, Christiansen H. Assessing ADHD symptoms in children and adults: evaluating the role of objective measures. Behav Brain Funct 2018;14:11. [PMID: 29776429 DOI: 10.1186/s12993-018-0143-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
268 Zaccari V, Santonastaso O, Mandolesi L, De Crescenzo F, Foti F, Crescentini C, Fabbro F, Vicari S, Curcio G, Menghini D. Clinical application of mindfulness-oriented meditation in children with ADHD: a preliminary study on sleep and behavioral problems. Psychol Health 2021;:1-17. [PMID: 33678073 DOI: 10.1080/08870446.2021.1892110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Antshel KM, Biederman J, Spencer TJ, Faraone SV. The Neuropsychological Profile of Comorbid Post-Traumatic Stress Disorder in Adult ADHD. J Atten Disord 2016;20:1047-55. [PMID: 24567364 DOI: 10.1177/1087054714522512] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
270 Mattingly GW, Weisler RH, Young J, Adeyi B, Dirks B, Babcock T, Lasser R, Scheckner B, Goodman DW. Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. BMC Psychiatry 2013;13:39. [PMID: 23356790 DOI: 10.1186/1471-244X-13-39] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
271 Popovic B, Bhattacharya P, Sivaswamy L. Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder. American Journal of Health-System Pharmacy 2009;66:2005-12. [DOI: 10.2146/ajhp080353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
272 Das D, Cherbuin N, Easteal S, Anstey KJ. Attention Deficit/Hyperactivity Disorder symptoms and cognitive abilities in the late-life cohort of the PATH through life study. PLoS One 2014;9:e86552. [PMID: 24489743 DOI: 10.1371/journal.pone.0086552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
273 Loskutova NY, Callen E, Pinckney RG, Staton EW, Pace WD. Feasibility, Implementation and Outcomes of Tablet-Based Two-Step Screening for Adult ADHD in Primary Care Practice. J Atten Disord 2021;25:794-802. [PMID: 31014157 DOI: 10.1177/1087054719841133] [Reference Citation Analysis]
274 Giacobini M, Medin E, Ahnemark E, Russo LJ, Carlqvist P. Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden. J Atten Disord 2018;22:3-13. [DOI: 10.1177/1087054714554617] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
275 Ebejer JL, Medland SE, van der Werf J, Gondro C, Henders AK, Lynskey M, Martin NG, Duffy DL. Attention deficit hyperactivity disorder in Australian adults: prevalence, persistence, conduct problems and disadvantage. PLoS One 2012;7:e47404. [PMID: 23071800 DOI: 10.1371/journal.pone.0047404] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
276 Hosain GM, Berenson AB, Tennen H, Bauer LO, Wu ZH. Attention deficit hyperactivity symptoms and risky sexual behavior in young adult women. J Womens Health (Larchmt) 2012;21:463-8. [PMID: 22303821 DOI: 10.1089/jwh.2011.2825] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
277 Mattingly GW, Wilson J, Ugarte L, Glaser P. Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions. CNS Spectr 2021;26:202-21. [PMID: 32054558 DOI: 10.1017/S1092852919001822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
278 Franke B, Vasquez AA, Johansson S, Hoogman M, Romanos J, Boreatti-Hümmer A, Heine M, Jacob CP, Lesch KP, Casas M, Ribasés M, Bosch R, Sánchez-Mora C, Gómez-Barros N, Fernàndez-Castillo N, Bayés M, Halmøy A, Halleland H, Landaas ET, Fasmer OB, Knappskog PM, Heister AJ, Kiemeney LA, Kooij JJ, Boonstra AM, Kan CC, Asherson P, Faraone SV, Buitelaar JK, Haavik J, Cormand B, Ramos-Quiroga JA, Reif A. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology 2010;35:656-64. [PMID: 19890261 DOI: 10.1038/npp.2009.170] [Cited by in Crossref: 133] [Cited by in F6Publishing: 135] [Article Influence: 10.2] [Reference Citation Analysis]
279 Thompson A, Steinbeis N. Sensitive periods in executive function development. Curr Opin Behav Sci 2020;36:98-105. [PMID: 33457470 DOI: 10.1016/j.cobeha.2020.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
280 Rommelse NN, Altink ME, Fliers EA, Martin NC, Buschgens CJ, Hartman CA, Buitelaar JK, Faraone SV, Sergeant JA, Oosterlaan J. Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes. Implications for a future DSM. J Abnorm Child Psychol 2009;37:793-804. [PMID: 19308723 DOI: 10.1007/s10802-009-9312-6] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
281 Cottle JE, Hall EE, Patel K, Barnes KP, Ketcham CJ. Concussion Baseline Testing: Preexisting Factors, Symptoms, and Neurocognitive Performance. J Athl Train 2017;52:77-81. [PMID: 28071936 DOI: 10.4085/1062-6050-51.12.21] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
282 Clemow DB. Misuse of Methylphenidate. Curr Top Behav Neurosci 2017;34:99-124. [PMID: 26695166 DOI: 10.1007/7854_2015_426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
283 Spencer TJ, Biederman J, Martin JM, Moorehead TM, Mirto T, Clarke A, Batchelder H, Faraone SV. Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential. Postgrad Med 2012;124:166-73. [PMID: 22314126 DOI: 10.3810/pgm.2012.01.2529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
284 Fuller-Thomson E, Lewis DA. The relationship between early adversities and attention-deficit/hyperactivity disorder. Child Abuse Negl 2015;47:94-101. [PMID: 25890666 DOI: 10.1016/j.chiabu.2015.03.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
285 Hegarty CE, Foland-Ross LC, Narr KL, Sugar CA, McGough JJ, Thompson PM, Altshuler LL. ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar disorder. Bipolar Disord 2012;14:843-55. [PMID: 23167934 DOI: 10.1111/bdi.12024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
286 Appelbaum KL. Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder. J Correct Health Care 2011;17:218-25. [PMID: 21474530 DOI: 10.1177/1078345811401356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
287 Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Relationships of Internet addiction and Internet gaming disorder symptom severities with probable attention deficit/hyperactivity disorder, aggression and negative affect among university students. Atten Defic Hyperact Disord 2019;11:413-21. [PMID: 31062235 DOI: 10.1007/s12402-019-00305-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
288 Weiss M, Murray C, Wasdell M, Greenfield B, Giles L, Hechtman L. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry 2012;12:30. [PMID: 22480189 DOI: 10.1186/1471-244X-12-30] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 6.2] [Reference Citation Analysis]
289 Rucklidge JJ, Downs-Woolley M, Taylor M, Brown JA, Harrow SE. Psychiatric Comorbidities in a New Zealand Sample of Adults With ADHD. J Atten Disord 2016;20:1030-8. [PMID: 24743977 DOI: 10.1177/1087054714529457] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
290 Rucklidge JJ, Frampton CM, Gorman B, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. Br J Psychiatry 2014;204:306-15. [PMID: 24482441 DOI: 10.1192/bjp.bp.113.132126] [Cited by in Crossref: 68] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
291 Kim BS, Chang SM, Park JE, Seong SJ, Won SH, Cho MJ. Prevalence, correlates, psychiatric comorbidities, and suicidality in a community population with problematic Internet use. Psychiatry Res 2016;244:249-56. [PMID: 27500456 DOI: 10.1016/j.psychres.2016.07.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
292 Chen VC, Yang YH, Liao YT, Kuo TY, Liang HY, Huang KY, Huang YC, Lee Y, McIntyre RS, Lin TC. The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan. PLoS One 2017;12:e0173762. [PMID: 28296941 DOI: 10.1371/journal.pone.0173762] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
293 Wymbs BT, Canu WH, Sacchetti GM, Ranson LM. Adult ADHD and romantic relationships: What we know and what we can do to help. J Marital Fam Ther 2021;47:664-81. [PMID: 33421168 DOI: 10.1111/jmft.12475] [Reference Citation Analysis]
294 Minzenberg MJ. Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits. Neurotherapeutics 2012;9:610-21. [PMID: 22718077 DOI: 10.1007/s13311-012-0128-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
295 Virta M, Vedenpää A, Grönroos N, Chydenius E, Partinen M, Vataja R, Kaski M, Iivanainen M. Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants. J Atten Disord 2008;12:218-26. [PMID: 18192618 DOI: 10.1177/1087054707311657] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
296 Bueno VF, da Silva MA, Alves TM, Louzã MR, Pompéia S. Fractionating Executive Functions of Adults With ADHD. J Atten Disord 2017;21:944-55. [PMID: 25104788 DOI: 10.1177/1087054714545537] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
297 Bloch Y, Aviram S, Segev A, Nitzan U, Levkovitz Y, Braw Y, Mimouni Bloch A. Methylphenidate Reduces State Anxiety During a Continuous Performance Test That Distinguishes Adult ADHD Patients From Controls. J Atten Disord 2017;21:46-51. [PMID: 23413186 DOI: 10.1177/1087054712474949] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
298 Mattos P, Coutinho G. Qualidade de vida e TDAH. J bras psiquiatr 2007;56:50-2. [DOI: 10.1590/s0047-20852007000500011] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
299 van den Ban EF, Souverein PC, van Engeland H, Swaab H, Egberts TCG, Heerdink ER. Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands. Soc Psychiatry Psychiatr Epidemiol 2015;50:1153-62. [DOI: 10.1007/s00127-015-1068-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
300 Thompson T, Lloyd A, Joseph A, Weiss M. The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis. Qual Life Res 2017;26:1879-85. [PMID: 28220338 DOI: 10.1007/s11136-017-1514-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
301 Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Hammerness P, Sitt DJ, Minerly C, Davidow JV, Faraone SV. Preliminary Examination of the Reliability and Concurrent Validity of the Attention-Deficit/Hyperactivity Disorder Self-Report Scale v1.1 Symptom Checklist to Rate Symptoms of Attention-Deficit/Hyperactivity Disorder in Adolescents. Journal of Child and Adolescent Psychopharmacology 2012;22:238-44. [DOI: 10.1089/cap.2011.0062] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
302 Wilens TE. ADHD: Prevalence, Diagnosis, and Issues of Comorbidity. CNS Spectr 2007;12:1-5. [DOI: 10.1017/s1092852900025992] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
303 Ahmadalipour A, Mehdizadeh Fanid L, Zeinalzadeh N, Alizadeh M, Vaezi H, Hassanpour Aydinlou Z, Noorazar SG. The first evidence of an association between a polymorphism in the endocannabinoid-degrading enzyme FAAH (FAAH rs2295633) with attention deficit hyperactivity disorder. Genomics 2020;112:1330-4. [DOI: 10.1016/j.ygeno.2019.07.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
304 Epstein I, Szpindel I, Katzman MA. Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies. Psychiatry Res 2014;220 Suppl 1:S15-33. [PMID: 25539871 DOI: 10.1016/S0165-1781(14)70003-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
305 Connor DF, Arnsten AF, Pearson GS, Greco GF. Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents. Expert Opinion on Pharmacotherapy 2014;15:1601-10. [DOI: 10.1517/14656566.2014.930437] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
306 Du Rietz E, Pettersson E, Brikell I, Ghirardi L, Chen Q, Hartman C, Lichtenstein P, Larsson H, Kuja-halkola R. Overlap between attention-deficit hyperactivity disorder and neurodevelopmental, externalising and internalising disorders: separating unique from general psychopathology effects. Br J Psychiatry 2021;218:35-42. [DOI: 10.1192/bjp.2020.152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
307 Strauß M, Petroff D, Huang J, Ulke C, Paucke M, Bogatsch H, Böhme P, Hoffmann K, Reif A, Kittel-Schneider S, Heuser I, Ahlers E, Gallinat J, Schöttle D, Fallgatter A, Ethofer T, Unterecker S, Hegerl U. The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients? Eur Neuropsychopharmacol 2021;43:116-28. [PMID: 33388218 DOI: 10.1016/j.euroneuro.2020.12.003] [Reference Citation Analysis]
308 Gjervan B, Torgersen T, Hjemdal O. The Norwegian Translation of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale: Validation and Assessment of QoL in 313 Adults With ADHD. J Atten Disord 2019;23:931-9. [PMID: 27033881 DOI: 10.1177/1087054716640087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
309 Hudak J, Rosenbaum D, Barth B, Fallgatter AJ, Ehlis AC. Functionally disconnected: A look at how study design influences neurofeedback data and mechanisms in attention-deficit/hyperactivity disorder. PLoS One 2018;13:e0200931. [PMID: 30096196 DOI: 10.1371/journal.pone.0200931] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
310 Hurst RM, Kepley HO, McCalla MK, Livermore MK. Internal consistency and discriminant validity of a delay-discounting task with an adult self-reported ADHD sample. J Atten Disord 2011;15:412-22. [PMID: 20439488 DOI: 10.1177/1087054710365993] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
311 Oguchi M, Takahashi T, Nitta Y, Kumano H. The Moderating Effect of Attention-Deficit Hyperactivity Disorder Symptoms on the Relationship Between Procrastination and Internalizing Symptoms in the General Adult Population. Front Psychol 2021;12:708579. [PMID: 34764902 DOI: 10.3389/fpsyg.2021.708579] [Reference Citation Analysis]
312 Fontana BD, Franscescon F, Rosemberg DB, Norton WH, Kalueff AV, Parker MO. Zebrafish models for attention deficit hyperactivity disorder (ADHD). Neuroscience & Biobehavioral Reviews 2019;100:9-18. [DOI: 10.1016/j.neubiorev.2019.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
313 Butzbach M, Fuermaier ABM, Aschenbrenner S, Weisbrod M, Tucha L, Tucha O. Metacognition, psychopathology and daily functioning in adult ADHD. J Clin Exp Neuropsychol 2021;43:384-98. [PMID: 34157944 DOI: 10.1080/13803395.2021.1940104] [Reference Citation Analysis]
314 Bukstein OG. Clinical practice guidelines for attention-deficit/hyperactivity disorder: a review. Postgrad Med 2010;122:69-77. [PMID: 20861590 DOI: 10.3810/pgm.2010.09.2203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
315 Fredriksen M, Peleikis DE. Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study. Basic Clin Pharmacol Toxicol 2016;118:23-31. [PMID: 26404187 DOI: 10.1111/bcpt.12477] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
316 Harpin V, Mazzone L, Raynaud JP, Kahle J, Hodgkins P. Long-Term Outcomes of ADHD: A Systematic Review of Self-Esteem and Social Function. J Atten Disord 2016;20:295-305. [PMID: 23698916 DOI: 10.1177/1087054713486516] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
317 Joshi G, Wilens T. Comorbidity in pediatric bipolar disorder. Child Adolesc Psychiatr Clin N Am. 2009;18:291-319, vii-viii. [PMID: 19264265 DOI: 10.1016/j.chc.2008.12.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
318 Scholiers J. Hoe gaan angst en depressie samen met ADHD? NEUROPRAXIS 2010;14:41-5. [DOI: 10.1007/s12474-010-0008-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
319 Pagoto SL, Curtin C, Lemon SC, Bandini LG, Schneider KL, Bodenlos JS, Ma Y. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity (Silver Spring) 2009;17:539-44. [PMID: 19131944 DOI: 10.1038/oby.2008.587] [Cited by in Crossref: 108] [Cited by in F6Publishing: 106] [Article Influence: 8.3] [Reference Citation Analysis]
320 Jenkins R, Othieno C, Ongeri L, Ogutu B, Sifuna P, Mboroki J, Omollo R. Attention deficit hyperactivity disorder symptom self-report in adults in Kenya and its associated risk factors, an analysis from a household survey in a demographic surveillance site. Glob Ment Health (Camb) 2015;2:e14. [PMID: 28596862 DOI: 10.1017/gmh.2015.14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
321 Fallgatter AJ, Ehlis AC, Dresler T, Reif A, Jacob CP, Arcos-Burgos M, Muenke M, Lesch KP. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD). Eur Neuropsychopharmacol 2013;23:458-68. [PMID: 23245769 DOI: 10.1016/j.euroneuro.2012.11.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
322 Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67. [PMID: 20815868 DOI: 10.1186/1471-244x-10-67] [Cited by in Crossref: 467] [Cited by in F6Publishing: 157] [Article Influence: 38.9] [Reference Citation Analysis]
323 Tischler L, Schmidt S, Petermann F, Koglin U. ADHS im Jugendalter: Symptomwandel und Konsequenzen für Forschung und klinische Praxis. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2010;58:23-34. [DOI: 10.1024/1661-4747.a000003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
324 Rozenek EB, Górska M, Wilczyńska K, Waszkiewicz N. In search of optimal psychoactivation: stimulants as cognitive performance enhancers. Arh Hig Rada Toksikol 2019;70:150-9. [PMID: 32597132 DOI: 10.2478/aiht-2019-70-3298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Harrison AG. Clinical, Ethical, and Forensic Implications of a Flexible Threshold for LD and ADHD in Postsecondary Settings. Psychol Inj and Law 2017;10:138-50. [DOI: 10.1007/s12207-017-9291-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
326 Goodman DW, Thase ME. Recognizing ADHD in Adults with Comorbid Mood Disorders: Implications for Identification and Management. Postgraduate Medicine 2015;121:31-41. [DOI: 10.3810/pgm.2009.09.2049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
327 Mattingly GW, Anderson RH. Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems. CNS Spectr 2016;21:45-59. [PMID: 28044946 DOI: 10.1017/S1092852916000808] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
328 Du Rietz E, Brikell I, Butwicka A, Leone M, Chang Z, Cortese S, D'Onofrio BM, Hartman CA, Lichtenstein P, Faraone SV, Kuja-Halkola R, Larsson H. Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study. Lancet Psychiatry 2021:S2215-0366(21)00171-1. [PMID: 34242595 DOI: 10.1016/S2215-0366(21)00171-1] [Reference Citation Analysis]
329 Garcia A, Kirkpatrick K. Impulsive choice behavior in four strains of rats: evaluation of possible models of Attention-Deficit/Hyperactivity Disorder. Behav Brain Res 2013;238:10-22. [PMID: 23085479 DOI: 10.1016/j.bbr.2012.10.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
330 Hodgkins P, Montejano L, Sasané R, Huse D. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord 2011;13:PCC. [PMID: 21977356 DOI: 10.4088/PCC.10m01030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
331 Engelhardt PE, Nigg JT, Carr LA, Ferreira F. Cognitive inhibition and working memory in attention-deficit/hyperactivity disorder. J Abnorm Psychol 2008;117:591-605. [PMID: 18729611 DOI: 10.1037/a0012593] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
332 Mitchell JT, Weisner TS, Jensen PS, Murray DW, Molina BSG, Arnold LE, Hechtman L, Swanson JM, Hinshaw SP, Victor EC, Kollins SH, Wells KC, Belendiuk KA, Blonde A, Nguyen C, Ambriz L, Nguyen JL. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord 2018;22:49S-60S. [PMID: 28166690 DOI: 10.1177/1087054716685842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
333 Camporeale A, Day KA, Ruff D, Arsenault J, Williams D, Kelsey DK. Profile of sexual and genitourinary treatment-emergent adverse events associated with atomoxetine treatment: a pooled analysis. Drug Saf 2013;36:663-71. [PMID: 23775507 DOI: 10.1007/s40264-013-0074-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
334 Paucke M, Stibbe T, Huang J, Strauss M. Differentiation of ADHD and Depression Based on Cognitive Performance. J Atten Disord 2021;25:920-32. [PMID: 31409195 DOI: 10.1177/1087054719865780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
335 Gray S, Woltering S, Mawjee K, Tannock R. The Adult ADHD Self-Report Scale (ASRS): utility in college students with attention-deficit/hyperactivity disorder. PeerJ 2014;2:e324. [PMID: 24711973 DOI: 10.7717/peerj.324] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
336 Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Current Opinion in Psychiatry 2007;20:386-92. [DOI: 10.1097/yco.0b013e3281568d7a] [Cited by in Crossref: 258] [Cited by in F6Publishing: 98] [Article Influence: 17.2] [Reference Citation Analysis]
337 Polyzoi M, Ahnemark E, Medin E, Ginsberg Y. Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study. Neuropsychiatr Dis Treat 2018;14:1149-61. [PMID: 29765219 DOI: 10.2147/NDT.S155838] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
338 Mccarthy J, Chaplin E, Underwood L, Forrester A, Hayward H, Sabet J, Young S, Asherson P, Mills R, Murphy D. Characteristics of prisoners with neurodevelopmental disorders and difficulties: Prisoners with neurodevelopmental disorders and difficulties. Journal of Intellectual Disability Research 2016;60:201-6. [DOI: 10.1111/jir.12237] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
339 Leroy A, Petit G, Zarka D, Cebolla A, Palmero-soler E, Strul J, Dan B, Verbanck P, Cheron G. EEG Dynamics and Neural Generators in Implicit Navigational Image Processing in Adults with ADHD. Neuroscience 2018;373:92-105. [DOI: 10.1016/j.neuroscience.2018.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
340 Evren B, Evren C, Dalbudak E, Topcu M, Kutlu N. The impact of depression, anxiety, neuroticism, and severity of Internet addiction symptoms on the relationship between probable ADHD and severity of insomnia among young adults. Psychiatry Res 2019;271:726-31. [PMID: 30791348 DOI: 10.1016/j.psychres.2018.12.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
341 Berkol TD, Yargiç İ, Özyildirim İ, Yazici O. Comorbidity of Adult Attention Deficit and Hyperactivity Disorder in Bipolar Patients: Prevalence, Sociodemographic and Clinical Correlates. Noro Psikiyatr Ars 2014;51:97-102. [PMID: 28360607 DOI: 10.4274/npa.y6376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
342 Carlotta D, Borroni S, Maffei C, Fossati A. On the relationship between retrospective childhood ADHD symptoms and adult BPD features: The mediating role of action-oriented personality traits. Comprehensive Psychiatry 2013;54:943-52. [DOI: 10.1016/j.comppsych.2013.03.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
343 Weber J, Siddiqui MAA. Lisdexamfetamine Dimesylate: In Attention-Deficit Hyperactivity Disorder in Adults. CNS Drugs 2009;23:419-25. [DOI: 10.2165/00023210-200923050-00005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
344 Reimer B, Mehler B, D’ambrosio LA, Fried R. The impact of distractions on young adult drivers with attention deficit hyperactivity disorder (ADHD). Accident Analysis & Prevention 2010;42:842-51. [DOI: 10.1016/j.aap.2009.06.021] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
345 Casas M, Rösler M, Sandra Kooij JJ, Ginsberg Y, Ramos-Quiroga JA, Heger S, Berwaerts J, Dejonckheere J, van der Vorst E, Schäuble B. Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose study. World J Biol Psychiatry 2013;14:268-81. [PMID: 22106853 DOI: 10.3109/15622975.2011.600333] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
346 Bilodeau M, Simon T, Beauchamp MH, Lespérance P, Dubreucq S, Dorée J, Tourjman SV. Duloxetine in Adults With ADHD: A Randomized, Placebo-Controlled Pilot Study. J Atten Disord 2014;18:169-75. [DOI: 10.1177/1087054712443157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
347 Cohen YG, Segev RW, Shlafman N, Novack V, Ifergane G. Methylphenidate use among medical students at Ben-Gurion University of the Negev. J Neurosci Rural Pract 2015;6:320-5. [PMID: 26167012 DOI: 10.4103/0976-3147.158749] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
348 Ahmann E, Smith K, Ellington L, Pille RO. Health and Wellness Coaching and Psychiatric Care Collaboration in a Multimodal Intervention for Attention-Deficit/Hyperactivity Disorder: A Case Report. Perm J 2019;24. [PMID: 31710834 DOI: 10.7812/TPP/18.256] [Reference Citation Analysis]
349 Sprich SE, Knouse LE, Cooper-Vince C, Burbridge J, Safren SA. Description and Demonstration of CBT for ADHD in Adults. Cogn Behav Pract 2012;17. [PMID: 24379644 DOI: 10.1016/j.cbpra.2009.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
350 Stickley A, Koyanagi A, Takahashi H, Ruchkin V, Inoue Y, Kamio Y. Attention-deficit/hyperactivity disorder and physical multimorbidity: A population-based study. Eur psychiatr 2017;45:227-34. [DOI: 10.1016/j.eurpsy.2017.07.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
351 Segenreich D, Fortes D, Coutinho G, Pastura G, Mattos P. Anxiety and depression in parents of a Brazilian non-clinical sample of attention-deficit/ hyperactivity disorder (ADHD) students. Braz J Med Biol Res 2009;42:465-9. [PMID: 19377797 DOI: 10.1590/s0100-879x2009000500011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
352 Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2007;257:371-7. [PMID: 17902010 DOI: 10.1007/s00406-007-0712-8] [Cited by in Crossref: 200] [Cited by in F6Publishing: 171] [Article Influence: 14.3] [Reference Citation Analysis]
353 McClernon FJ, Van Voorhees EE, English J, Hallyburton M, Holdaway A, Kollins SH. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res 2011;13:784-92. [PMID: 21571687 DOI: 10.1093/ntr/ntr073] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
354 Mrazik M, Naidu D, Borza C, Kobitowich T, Shergill S. King Devick computerized neurocognitive test scores in professional football players with learning and attentional disabilities. Journal of the Neurological Sciences 2019;399:140-3. [DOI: 10.1016/j.jns.2019.02.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
355 Adler LA, Faraone SV, Sarocco P, Atkins N, Khachatryan A. Establishing US norms for the Adult ADHD Self-Report Scale (ASRS-v1.1) and characterising symptom burden among adults with self-reported ADHD. Int J Clin Pract 2019;73:e13260. [PMID: 30239073 DOI: 10.1111/ijcp.13260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
356 Oh Y, Park H, Kim S, Kim HS, Joung YS, Hong KS, Baek JH. Psychopathologic Profiles and Clusters in Tertiary Clinic Referred Patients with Adult Attention Deficit Hyperactivity Disorder: A Person-Centered Analysis. Psychiatry Investig 2021;18:304-11. [PMID: 33951777 DOI: 10.30773/pi.2020.0331] [Reference Citation Analysis]
357 Cerrillo-Urbina AJ, García-Hermoso A, Pardo-Guijarro MJ, Sánchez-López M, Santos-Gómez JL, Martínez-Vizcaíno V. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials. J Child Adolesc Psychopharmacol 2018;28:494-507. [PMID: 29897263 DOI: 10.1089/cap.2017.0151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
358 Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P, Nicastro R, Hasler R, Nallet A, Piguet C, Paoloni-Giacobino A, Aubry JM, Dayer A. METHYLATION OF SEROTONIN RECEPTOR 3A IN ADHD, BORDERLINE PERSONALITY, AND BIPOLAR DISORDERS: LINK WITH SEVERITY OF THE DISORDERS AND CHILDHOOD MALTREATMENT. Depress Anxiety 2016;33:45-55. [PMID: 26350166 DOI: 10.1002/da.22406] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 9.3] [Reference Citation Analysis]
359 Hutchison SL, Ghuman JK, Ghuman HS, Karpov I, Schuster JM. Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review. Ther Adv Psychopharmacol. 2016;6:317-334. [PMID: 27721971 DOI: 10.1177/2045125316647686] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
360 Yuen T, Zhang H, Bonin RP. Pharmacists' knowledge, experiences and perceptions of treatments for attention-deficit/hyperactivity disorder. Can Pharm J (Ott) 2021;154:110-9. [PMID: 33868522 DOI: 10.1177/1715163520981397] [Reference Citation Analysis]
361 Wolfe ES, Madden KJ. Evidence-Based Considerations and Recommendations for Athletic Trainers Caring for Patients With Attention-Deficit/Hyperactivity Disorder. J Athl Train 2016;51:813-20. [PMID: 27834506 DOI: 10.4085/1062-6050-51.12.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
362 Solanto MV, Surman CB, Alvir JMJ. The efficacy of cognitive-behavioral therapy for older adults with ADHD: a randomized controlled trial. Atten Defic Hyperact Disord 2018;10:223-35. [PMID: 29492784 DOI: 10.1007/s12402-018-0253-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
363 Cowles BJ. Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine. Ther Clin Risk Manag 2009;5:943-8. [PMID: 20057893 DOI: 10.2147/tcrm.s6733] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
364 Chamberlain SR, Ioannidis K, Leppink EW, Niaz F, Redden SA, Grant JE. ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity. CNS Spectr 2017;22:22-30. [PMID: 27680974 DOI: 10.1017/S1092852915000875] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
365 Asherson P, Stes S, Nilsson Markhed M, Berggren L, Svanborg P, Kutzelnigg A, Deberdt W. The effects of atomoxetine on emotional control in adults with ADHD: An integrated analysis of multicenter studies. Eur psychiatr 2015;30:511-20. [DOI: 10.1016/j.eurpsy.2014.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
366 Fedele DA, Hartung CM, Canu WH, Wilkowski BM. Potential Symptoms of ADHD for Emerging Adults. J Psychopathol Behav Assess 2010;32:385-96. [DOI: 10.1007/s10862-009-9173-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
367 Instanes JT, Haavik J, Halmøy A. Personality Traits and Comorbidity in Adults With ADHD. J Atten Disord 2016;20:845-54. [DOI: 10.1177/1087054713511986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
368 Agranat-Meged A, Ghanadri Y, Eisenberg I, Ben Neriah Z, Kieselstein-Gross E, Mitrani-Rosenbaum S. Attention deficit hyperactivity disorder in obese melanocortin-4-receptor (MC4R) deficient subjects: a newly described expression of MC4R deficiency. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1547-53. [PMID: 18777518 DOI: 10.1002/ajmg.b.30842] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
369 Vaughan BS, Wetzel MW, Kratochvil CJ. Beyond the ‘typical’ patient: Treating attention-deficit/hyperactivity disorder in preschoolers and adults. International Review of Psychiatry 2009;20:143-9. [DOI: 10.1080/09540260801887751] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
370 Pierson C, Waite E, Pyykkonen B. A meta-analysis of the neuropsychological effects of chemotherapy in the treatment of childhood cancer. Pediatr Blood Cancer 2016;63:1998-2003. [PMID: 27463220 DOI: 10.1002/pbc.26117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
371 Fasmer OB, Halmøy A, Oedegaard KJ, Haavik J. Adult attention deficit hyperactivity disorder is associated with migraine headaches. Eur Arch Psychiatry Clin Neurosci 2011;261:595-602. [PMID: 21394551 DOI: 10.1007/s00406-011-0203-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
372 Minahim D, Rohde LA. Attention deficit hyperactivity disorder and intellectual giftedness: a study of symptom frequency and minor physical anomalies. Braz J Psychiatry 2015;37:289-95. [PMID: 26692428 DOI: 10.1590/1516-4446-2014-1489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
373 Young S, González RA, Mullens H, Mutch L, Malet-Lambert I, Gudjonsson GH. Neurodevelopmental disorders in prison inmates: comorbidity and combined associations with psychiatric symptoms and behavioural disturbance. Psychiatry Res 2018;261:109-15. [PMID: 29291476 DOI: 10.1016/j.psychres.2017.12.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
374 Marshall P, Hoelzle J, Nikolas M. Diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD) in young adults: A qualitative review of the utility of assessment measures and recommendations for improving the diagnostic process. Clin Neuropsychol 2021;35:165-98. [PMID: 31791193 DOI: 10.1080/13854046.2019.1696409] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
375 Mcgillivray J, Baker K. Effects of Comorbid ADHD with Learning Disabilities on Anxiety, Depression, and Aggression in Adults. J Atten Disord 2009;12:525-31. [DOI: 10.1177/1087054708320438] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
376 Bassiony MM, Mahdy RS, Haggag N, Salah Eldeen G. Current attention-deficit/hyperactivity disorder and nonmedical prescription opioid use attributed to tramadol among male adolescents without conduct disorder in Egypt. Am J Drug Alcohol Abuse 2021;:1-7. [PMID: 34280063 DOI: 10.1080/00952990.2021.1944172] [Reference Citation Analysis]
377 Goodman DW, Mitchell S, Rhodewalt L, Surman CBH. Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care. Drugs Aging 2016;33:27-36. [DOI: 10.1007/s40266-015-0327-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
378 Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, Lepine JP, Mazzi F, Reneses B, Vilagut G, Sampson NA, Kessler RC. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res 2006;15:167-80. [PMID: 17266013 DOI: 10.1002/mpr.196] [Cited by in Crossref: 697] [Cited by in F6Publishing: 709] [Article Influence: 46.5] [Reference Citation Analysis]
379 Antshel KM, Barkley R. Attention deficit hyperactivity disorder. Handb Clin Neurol 2020;174:37-45. [PMID: 32977893 DOI: 10.1016/B978-0-444-64148-9.00003-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
380 Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D. Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder: A 6-Month, Double-Blind Trial. Journal of Clinical Psychopharmacology 2009;29:44-50. [DOI: 10.1097/jcp.0b013e318192e4a0] [Cited by in Crossref: 92] [Cited by in F6Publishing: 27] [Article Influence: 7.1] [Reference Citation Analysis]
381 Childress AC, Uchida CL, Po MD, DeSousa NJ, Incledon B. A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial. Clin Ther 2020;42:2332-40. [PMID: 33168234 DOI: 10.1016/j.clinthera.2020.10.004] [Reference Citation Analysis]
382 Vogel T, Dom G, van de Glind G, Studer J, Gmel G, Strik W, Moggi F. Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men. Addiction. 2016;111:1867-1878. [PMID: 27061514 DOI: 10.1111/add.13422] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
383 Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 2012;10:99. [PMID: 22947230 DOI: 10.1186/1741-7015-10-99] [Cited by in Crossref: 290] [Cited by in F6Publishing: 236] [Article Influence: 29.0] [Reference Citation Analysis]
384 Leasure JL, Giddabasappa A, Chaney S, Johnson JE Jr, Pothakos K, Lau YS, Fox DA. Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ Health Perspect 2008;116:355-61. [PMID: 18335103 DOI: 10.1289/ehp.10862] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 6.1] [Reference Citation Analysis]
385 Roberts AL, Liew Z, Lyall K, Ascherio A, Weisskopf MG. Association of Maternal Exposure to Childhood Abuse With Elevated Risk for Attention Deficit Hyperactivity Disorder in Offspring. Am J Epidemiol 2018;187:1896-906. [PMID: 29762636 DOI: 10.1093/aje/kwy098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
386 Vidal R, Castells J, Richarte V, Palomar G, García M, Nicolau R, Lazaro L, Casas M, Ramos-Quiroga JA. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2015;54:275-82. [PMID: 25791144 DOI: 10.1016/j.jaac.2014.12.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
387 Marmet S, Studer J, Grazioli VS, Gmel G. Bidirectional Associations Between Self-Reported Gaming Disorder and Adult Attention Deficit Hyperactivity Disorder: Evidence From a Sample of Young Swiss Men. Front Psychiatry 2018;9:649. [PMID: 30618855 DOI: 10.3389/fpsyt.2018.00649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
388 Andersson A, Tuvblad C, Chen Q, Du Rietz E, Cortese S, Kuja-Halkola R, Larsson H. Research Review: The strength of the genetic overlap between ADHD and other psychiatric symptoms - a systematic review and meta-analysis. J Child Psychol Psychiatry 2020;61:1173-83. [PMID: 32157695 DOI: 10.1111/jcpp.13233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
389 Trantou A, Carlsen HK, Anderson C, Steingrimsson S. Sickness Absence Recommendation Among Outpatients With ADHD and Comorbidity: A Latent Class Analysis. J Atten Disord 2021;25:209-16. [PMID: 29882460 DOI: 10.1177/1087054718780338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
390 Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Sitt DJ, Minerly AE, Davidow JV, Faraone SV. Preliminary reliability and validity of a new time-sensitive ADHD symptom scale in adolescents with ADHD. Postgrad Med 2011;123:7-13. [PMID: 21904082 DOI: 10.3810/pgm.2011.09.2455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
391 Arnold VK, Feifel D, Earl CQ, Yang R, Adler LA. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. J Atten Disord 2014;18:133-44. [PMID: 22617860 DOI: 10.1177/1087054712441969] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
392 Weiss M, Safren SA, Solanto MV, Hechtman L, Rostain AL, Ramsay JR, Murray C. Research forum on psychological treatment of adults with ADHD. J Atten Disord 2008;11:642-51. [PMID: 18417729 DOI: 10.1177/1087054708315063] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
393 Vinker-Shuster M, Eldor R, Green I, Golan-Cohen A, Manor I, Merzon E. Glycemic Control and Diabetes Related Complications in Adults with Type 1 Diabetes Mellitus and ADHD. J Atten Disord 2021;:10870547211068039. [PMID: 34933573 DOI: 10.1177/10870547211068039] [Reference Citation Analysis]
394 Cassidy TA, McNaughton EC, Varughese S, Russo L, Zulueta M, Butler SF. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system. J Atten Disord 2015;19:275-83. [PMID: 23900405 DOI: 10.1177/1087054713493321] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
395 Garcia C, Bau C, Silva K, Callegari-jacques S, Salgado C, Fischer A, Victor M, Sousa N, Karam R, Rohde L, Belmonte-de-abreu P, Grevet E. The burdened life of adults with ADHD: Impairment beyond comorbidity. Eur psychiatr 2012;27:309-13. [DOI: 10.1016/j.eurpsy.2010.08.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 20.5] [Reference Citation Analysis]
396 Fargason RE, Fobian AD, Hablitz LM, Paul JR, White BA, Cropsey KL, Gamble KL. Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: A pilot study. J Psychiatr Res 2017;91:105-10. [PMID: 28327443 DOI: 10.1016/j.jpsychires.2017.03.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
397 Treur JL, Willemsen G, Bartels M, Geels LM, van Beek JH, Huppertz C, van Beijsterveldt CE, Boomsma DI, Vink JM. Smoking During Adolescence as a Risk Factor for Attention Problems. Biological Psychiatry 2015;78:656-63. [DOI: 10.1016/j.biopsych.2014.06.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
398 Jardin B, Looby A, Earleywine M. Characteristics of College Students With Attention-Deficit Hyperactivity Disorder Symptoms Who Misuse Their Medications. Journal of American College Health 2011;59:373-7. [DOI: 10.1080/07448481.2010.513073] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
399 Langley K, Martin J, Agha SS, Davies C, Stergiakouli E, Holmans P, Williams N, Owen M, O'Donovan M, Thapar A. Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants. Br J Psychiatry 2011;199:398-403. [PMID: 22045946 DOI: 10.1192/bjp.bp.111.092130] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
400 McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry 2012;12:219. [PMID: 23216881 DOI: 10.1186/1471-244X-12-219] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
401 Rosenblum S, Yom-Tov E. Seeking Web-Based Information About Attention Deficit Hyperactivity Disorder: Where, What, and When. J Med Internet Res 2017;19:e126. [PMID: 28432038 DOI: 10.2196/jmir.6579] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
402 Notzon DP, Pavlicova M, Glass A, Mariani JJ, Mahony AL, Brooks DJ, Levin FR. ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. J Atten Disord 2020;24:1487-92. [PMID: 27033880 DOI: 10.1177/1087054716640109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
403 Vaag JR, Lara-Cabrera ML, Hjemdal O, Gjervan B, Torgersen T. Psychoeducational groups versus waitlist in treatment of attention-deficit hyperactivity/impulsivity disorder (ADHD) in adults: a protocol for a pilot randomized waitlist-controlled multicenter trial. Pilot Feasibility Stud 2019;5:17. [PMID: 30693097 DOI: 10.1186/s40814-019-0401-1] [Reference Citation Analysis]
404 Canu WH, Tabor LS, Michael KD, Bazzini DG, Elmore AL. Young Adult Romantic Couples’ Conflict Resolution and Satisfaction Varies with Partner's Attention-Deficit/Hyperactivity Disorder Type. J Marital Fam Ther 2014;40:509-24. [DOI: 10.1111/jmft.12018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
405 Yılmaz E, Tamam L. Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatr Dis Treat 2018;14:1883-9. [PMID: 30100723 DOI: 10.2147/NDT.S159312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
406 Korzyukov O, Tapaskar N, Pflieger ME, Behroozmand R, Lodhavia A, Patel S, Robin DA, Larson C. Event related potentials study of aberrations in voice control mechanisms in adults with attention deficit hyperactivity disorder. Clin Neurophysiol 2015;126:1159-70. [PMID: 25308310 DOI: 10.1016/j.clinph.2014.09.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
407 Cicek D, Kandi B, Dertlioglu SB, Gunay S, Halisdemir N, Turgay A, Colak C. Investigation of attention deficit and hyperactivity disorder in adult patients with atopic dermatitis. Int J Psychiatry Clin Pract 2009;13:292-7. [PMID: 24916939 DOI: 10.3109/13651500902999212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
408 Tseregounis IE, Stewart SL, Crawford A, Marshall BDL, Cerdá M, Shev AB, Henry SG. Age- and Sex-Specific Increases in Stimulant Prescribing Rates-California, 2008-2017. J Atten Disord 2020;24:205-14. [PMID: 31680608 DOI: 10.1177/1087054719883008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
409 Prakash J, Chatterjee K, Guha S, Srivastava K, Chauhan VS. Adult attention-deficit Hyperactivity disorder: From clinical reality toward conceptual clarity. Ind Psychiatry J 2021;30:23-8. [PMID: 34483520 DOI: 10.4103/ipj.ipj_7_21] [Reference Citation Analysis]
410 Clemow DB, Bushe C, Mancini M, Ossipov MH, Upadhyaya H. A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatr Dis Treat 2017;13:357-71. [PMID: 28223809 DOI: 10.2147/NDT.S115707] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
411 Hupfeld KE, Abagis TR, Shah P. Living “in the zone”: hyperfocus in adult ADHD. ADHD Atten Def Hyp Disord 2019;11:191-208. [DOI: 10.1007/s12402-018-0272-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
412 Eddy LD, Will H. C, Broman-fulks JJ, Michael KD. Brief Cognitive Behavioral Therapy for College Students With ADHD: A Case Series Report. Cognitive and Behavioral Practice 2015;22:127-40. [DOI: 10.1016/j.cbpra.2014.05.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
413 Babinski DE, Neely KA, Ba DM, Liu G. Depression and Suicidal Behavior in Young Adult Men and Women With ADHD: Evidence From Claims Data. J Clin Psychiatry 2020;81:19m13130. [PMID: 32965804 DOI: 10.4088/JCP.19m13130] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
414 Fried R, Surman C, Hammerness P, Petty C, Faraone S, Hyder L, Westerberg D, Small J, Corkum L, Claudat K, Biederman J. A controlled study of a simulated workplace laboratory for adults with attention deficit hyperactivity disorder. Psychiatry Res 2012;200:949-56. [PMID: 22608823 DOI: 10.1016/j.psychres.2012.04.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
415 Torres I, Gómez N, Colom F, Jiménez E, Bosch R, Bonnín CM, Martínez-aran A, Casas M, Vieta E, Ramos-quiroga JA, Goikolea JM. Bipolar disorder with comorbid attention-deficit and hyperactivity disorder. Main clinical features and clues for an accurate diagnosis. Acta Psychiatr Scand 2015;132:389-99. [DOI: 10.1111/acps.12426] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
416 Pozzi M, Carnovale C, Peeters GGAM, Gentili M, Antoniazzi S, Radice S, Clementi E, Nobile M. Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis. J Affect Disord 2018;238:161-78. [PMID: 29883938 DOI: 10.1016/j.jad.2018.05.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
417 Jain R, Stark JG. Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications. Postgraduate Medicine 2016;128:672-81. [DOI: 10.1080/00325481.2016.1218259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
418 Nelson JM, Gregg N. Depression and anxiety among transitioning adolescents and college students with ADHD, dyslexia, or comorbid ADHD/dyslexia. J Atten Disord 2012;16:244-54. [PMID: 20978271 DOI: 10.1177/1087054710385783] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
419 Demeter CA, Youngstrom EA, Carlson GA, Frazier TW, Rowles BM, Lingler J, Mcnamara NK, Difrancesco KE, Calabrese JR, Findling RL. Age differences in the phenomenology of pediatric bipolar disorder. Journal of Affective Disorders 2013;147:295-303. [DOI: 10.1016/j.jad.2012.11.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
420 Thapar A, Langley K, Owen MJ, O'Donovan MC. Advances in genetic findings on attention deficit hyperactivity disorder. Psychol Med 2007;37:1681-92. [PMID: 17506925 DOI: 10.1017/S0033291707000773] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
421 Koyuncu A, Çelebi F, Ertekin E, Kök BE, Tükel R. Clinical Effects of ADHD Subtypes in Patients With Social Anxiety Disorder. J Atten Disord 2019;23:1464-9. [PMID: 26637843 DOI: 10.1177/1087054715617533] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
422 Wymbs BT, Wymbs FA, Dawson AE. Child ADHD and ODD behavior interacts with parent ADHD symptoms to worsen parenting and interparental communication. J Abnorm Child Psychol 2015;43:107-19. [PMID: 24882503 DOI: 10.1007/s10802-014-9887-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.9] [Reference Citation Analysis]
423 Michielsen M, Comijs HC, Aartsen MJ, Semeijn EJ, Beekman ATF, Deeg DJH, Kooij JJS. The Relationships Between ADHD and Social Functioning and Participation in Older Adults in a Population-Based Study. J Atten Disord 2015;19:368-79. [DOI: 10.1177/1087054713515748] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
424 Mautner V, Granström S, Leark RA. Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems. J Atten Disord 2015;19:35-43. [DOI: 10.1177/1087054712450749] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
425 Bukstein OG. Attention Deficit Hyperactivity Disorder and Substance Use Disorders. In: Stanford C, Tannock R, editors. Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment. Berlin: Springer Berlin Heidelberg; 2012. pp. 145-72. [DOI: 10.1007/7854_2011_148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
426 Caballero J, Darsey EH, Walters F, Belden HW. Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists. Integr Pharm Res Pract 2017;6:163-71. [PMID: 29354563 DOI: 10.2147/IPRP.S142576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
427 Kouros I, Hörberg N, Ekselius L, Ramklint M. Wender Utah Rating Scale-25 (WURS-25): psychometric properties and diagnostic accuracy of the Swedish translation. Ups J Med Sci 2018;123:230-6. [PMID: 30373435 DOI: 10.1080/03009734.2018.1515797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
428 Du J, Wang L, Jie B, Zhang D. Network-based classification of ADHD patients using discriminative subnetwork selection and graph kernel PCA. Comput Med Imaging Graph 2016;52:82-8. [PMID: 27166430 DOI: 10.1016/j.compmedimag.2016.04.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
429 Evren C, Cicikci E, Umut G, Evren B, Durmus K. Relationships of attention-deficit hyperactivity disorder with defense styles and harm avoidance among male inpatients with alcohol use disorder. Indian J Psychiatry 2019;61:584-91. [PMID: 31896864 DOI: 10.4103/psychiatry.IndianJPsychiatry_318_18] [Reference Citation Analysis]
430 McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr 2012;12:78. [PMID: 22712630 DOI: 10.1186/1471-2431-12-78] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 13.4] [Reference Citation Analysis]
431 Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2015;72:593-602. [PMID: 25887096 DOI: 10.1001/jamapsychiatry.2015.41] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 11.4] [Reference Citation Analysis]
432 Adamou M, Bowers S. Dose of Methylphenidate during Service Transition for Adults with ADHD. Ther Adv Psychopharmacol 2011;1:71-5. [PMID: 23983928 DOI: 10.1177/2045125311411603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
433 Culpepper L, Mattingly G. A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgrad Med 2008;120:16-26. [PMID: 18824822 DOI: 10.3810/pgm.2008.09.1904] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
434 Newcorn JH. Co-morbidity in Adults with ADHD. CNS Spectr 2008;13:12-5. [DOI: 10.1017/s1092852900003199] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
435 Kabul S, Alatorre C, Montejano LB, Farr AM, Clemow DB. Real-World Dosing Patterns of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder. CNS Neurosci Ther 2015;21:936-42. [PMID: 26331467 DOI: 10.1111/cns.12442] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
436 Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA. The Adult ADHD Quality Measures Initiative. J Atten Disord 2019;23:1063-78. [PMID: 30511593 DOI: 10.1177/1087054718804354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
437 Miguel PM, Deniz BF, Deckmann I, Confortim HD, Diaz R, Laureano DP, Silveira PP, Pereira LO. Prefrontal cortex dysfunction in hypoxic-ischaemic encephalopathy contributes to executive function impairments in rats: Potential contribution for attention-deficit/hyperactivity disorder. The World Journal of Biological Psychiatry 2018;19:547-60. [DOI: 10.1080/15622975.2016.1273551] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
438 Perugi G, Ceraudo G, Vannucchi G, Rizzato S, Toni C, Dell'osso L. Attention Deficit/Hyperactivity Disorder symptoms in Italian bipolar adult patients: A preliminary report. Journal of Affective Disorders 2013;149:430-4. [DOI: 10.1016/j.jad.2012.12.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
439 Norén Selinus E, Molero Y, Lichtenstein P, Larson T, Lundström S, Anckarsäter H, Gumpert CH. Childhood Symptoms of ADHD Overrule Comorbidity in Relation to Psychosocial Outcome at Age 15: A Longitudinal Study. PLoS One 2015;10:e0137475. [PMID: 26360378 DOI: 10.1371/journal.pone.0137475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
440 Almeida Montes LG, Prado Alcántara H, Martínez García RB, De La Torre LB, Ávila Acosta D, Duarte MG. Brain Cortical Thickness in ADHD: Age, Sex, and Clinical Correlations. J Atten Disord 2013;17:641-54. [DOI: 10.1177/1087054711434351] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
441 Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, Ustün TB, Zaslavsky AM. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005;57:1442-51. [PMID: 15950019 DOI: 10.1016/j.biopsych.2005.04.001] [Cited by in Crossref: 385] [Cited by in F6Publishing: 322] [Article Influence: 22.6] [Reference Citation Analysis]
442 Kay GG, Michaels MA, Pakull B. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. J Atten Disord 2009;12:316-29. [PMID: 18815438 DOI: 10.1177/1087054708322986] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
443 Hinshaw SP, Nguyen PT, O'Grady SM, Rosenthal EA. Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry 2021. [PMID: 34231220 DOI: 10.1111/jcpp.13480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Iaccarino MA, Fitzgerald M, Pulli A, Woodworth KY, Spencer TJ, Zafonte R, Biederman J. Sport concussion and attention deficit hyperactivity disorder in student athletes: A cohort study. Neurol Clin Pract 2018;8:403-11. [PMID: 30564494 DOI: 10.1212/CPJ.0000000000000525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
445 Kim D, Lee D, Lee J, Namkoong K, Jung YC. Association between childhood and adult attention deficit hyperactivity disorder symptoms in Korean young adults with Internet addiction. J Behav Addict 2017;6:345-53. [PMID: 28786707 DOI: 10.1556/2006.6.2017.044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
446 Kim J. Psychological issues and problematic use of smartphone: ADHD's moderating role in the associations among loneliness, need for social assurance, need for immediate connection, and problematic use of smartphone. Computers in Human Behavior 2018;80:390-8. [DOI: 10.1016/j.chb.2017.11.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
447 Gordon CT, Hinshaw SP. Executive Functions in Girls With and Without Childhood ADHD Followed Through Emerging Adulthood: Developmental Trajectories. J Clin Child Adolesc Psychol 2020;49:509-23. [PMID: 31039045 DOI: 10.1080/15374416.2019.1602840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
448 Becker SP, Jarrett MA, Luebbe AM, Garner AA, Burns GL, Kofler MJ. Sleep in a large, multi-university sample of college students: sleep problem prevalence, sex differences, and mental health correlates. Sleep Health 2018;4:174-81. [PMID: 29555131 DOI: 10.1016/j.sleh.2018.01.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 66] [Article Influence: 21.3] [Reference Citation Analysis]
449 Lewandowski LJ, Lovett BJ, Codding RS, Gordon M. Symptoms of ADHD and Academic Concerns in College Students With and Without ADHD Diagnoses. J Atten Disord 2008;12:156-61. [DOI: 10.1177/1087054707310882] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
450 Mathews CL, Morrell HER, Molle JE. Video game addiction, ADHD symptomatology, and video game reinforcement. Am J Drug Alcohol Abuse 2019;45:67-76. [PMID: 29874473 DOI: 10.1080/00952990.2018.1472269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
451 Haegerich TM, Hall JE. Violence and Men’s Health: Understanding the Etiological Underpinnings of Men’s Experiences With Interpersonal Violence. American Journal of Lifestyle Medicine 2011;5:440-53. [DOI: 10.1177/1559827611410263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
452 London AS, Landes SD. Cohort Change in the Prevalence of ADHD Among U.S. Adults: Evidence of a Gender-Specific Historical Period Effect. J Atten Disord 2021;25:771-82. [PMID: 31189421 DOI: 10.1177/1087054719855689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
453 Camp A, Pastrano A, Gomez V, Stephenson K, Delatte W, Perez B, Syas H, Guiseppi-Elie A. Understanding ADHD: Toward an Innovative Therapeutic Intervention. Bioengineering (Basel) 2021;8:56. [PMID: 34062853 DOI: 10.3390/bioengineering8050056] [Reference Citation Analysis]
454 Irfan M, Daraio T, Bark C. SNAP-25 Puts SNAREs at Center Stage in Metabolic Disease. Neuroscience 2019;420:86-96. [DOI: 10.1016/j.neuroscience.2018.07.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
455 Dennis ML, Chan YF, Funk RR. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am J Addict 2006;15 Suppl 1:80-91. [PMID: 17182423 DOI: 10.1080/10550490601006055] [Cited by in Crossref: 235] [Cited by in F6Publishing: 210] [Article Influence: 15.7] [Reference Citation Analysis]
456 Murphy D, Glaser K, Hayward H, Eklund H, Cadman T, Findon J, Woodhouse E, Ashwood K, Beecham J, Bolton P, Mcewen F, Wilson E, Ecker C, Wong I, Simonoff E, Russell A, Mccarthy J, Chaplin E, Young S, Asherson P. Crossing the divide: a longitudinal study of effective treatments for people with autism and attention deficit hyperactivity disorder across the lifespan. Programme Grants Appl Res 2018;6:1-240. [DOI: 10.3310/pgfar06020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Larsson H, Rydén E, Boman M, Långström N, Lichtenstein P, Landén M. Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. Br J Psychiatry 2013;203:103-6. [PMID: 23703314 DOI: 10.1192/bjp.bp.112.120808] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 11.7] [Reference Citation Analysis]
458 Andreasen JT, Redrobe JP, Nielsen EØ, Christensen JK, Olsen GM, Peters D. A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances. Neuropharmacology 2013;73:183-91. [DOI: 10.1016/j.neuropharm.2013.04.060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
459 Darracq MA, Thornton SL. Sustained stimulation? Characteristics of modified release and immediate release stimulant exposures reported to the national poison data system. Clin Toxicol (Phila) 2021;59:200-7. [PMID: 32609552 DOI: 10.1080/15563650.2020.1787428] [Reference Citation Analysis]
460 Virta M, Hiltunen S, Mattsson M, Kallio S. The impact of hypnotic suggestions on reaction times in continuous performance test in adults with ADHD and healthy controls. PLoS One 2015;10:e0126497. [PMID: 25962151 DOI: 10.1371/journal.pone.0126497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
461 Mota NR, Rovaris DL, Kappel DB, Picon FA, Vitola ES, Salgado CA, Karam RG, Rohde LA, Grevet EH, Bau CH. NCAM1-TTC12-ANKK1-DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 2015;168:433-44. [PMID: 25989041 DOI: 10.1002/ajmg.b.32317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
462 Trenque T, Herlem E, Abou Taam M, Drame M. Methylphenidate off-label use and safety. Springerplus 2014;3:286. [PMID: 25279275 DOI: 10.1186/2193-1801-3-286] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
463 Cunill R, Castells X, Tobias A, Capellà D. Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. J Psychopharmacol 2015;29:15-23. [PMID: 25142405 DOI: 10.1177/0269881114544777] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
464 Li W, Zhang W, Xiao L, Nie J. The association of Internet addiction symptoms with impulsiveness, loneliness, novelty seeking and behavioral inhibition system among adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Res 2016;243:357-64. [PMID: 27449004 DOI: 10.1016/j.psychres.2016.02.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
465 Wymbs B, Molina B, Pelham W, Cheong J, Gnagy E, Belendiuk K, Walther C, Babinski D, Waschbusch D. Risk of intimate partner violence among young adult males with childhood ADHD. J Atten Disord 2012;16:373-83. [PMID: 22044962 DOI: 10.1177/1087054710389987] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
466 Koyuncu A, Çelebi F, Ertekin E, Memiş ÇÖ, Tükel R. The Presence of Childhood Attention Deficit/Hyperactivity Disorder May Be Associated With Interpersonal Sensitivity in Patients With Social Anxiety Disorder. J Psychiatr Pract 2017;23:254-9. [PMID: 28749829 DOI: 10.1097/PRA.0000000000000246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
467 Kollins SH, English JS, Roley ME, O'Brien B, Blair J, Lane SD, McClernon FJ. Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. Psychopharmacology (Berl) 2013;227:19-30. [PMID: 23247366 DOI: 10.1007/s00213-012-2937-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
468 Stickley A, Koyanagi A, Ruchkin V, Kamio Y. Attention-deficit/hyperactivity disorder symptoms and suicide ideation and attempts: Findings from the Adult Psychiatric Morbidity Survey 2007. J Affect Disord 2016;189:321-8. [PMID: 26469299 DOI: 10.1016/j.jad.2015.09.061] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
469 Moggi F, Schorno D, Soravia LM, Mohler-Kuo M, Estévez-Lamorte N, Studer J, Gmel G. Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men. Eur Addict Res 2020;26:233-44. [PMID: 32564034 DOI: 10.1159/000508304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
470 Humphreys KL, Mehta N, Lee SS. Association of parental ADHD and depression with externalizing and internalizing dimensions of child psychopathology. J Atten Disord 2012;16:267-75. [PMID: 21173429 DOI: 10.1177/1087054710387264] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
471 Agosti V, Chen Y, Levin FR. Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts? J Affect Disord. 2011;133:595-599. [PMID: 21658780 DOI: 10.1016/j.jad.2011.05.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
472 Lowe TL, Capriotti MR, McBurnett K. Long-Term Follow-up of Patients with Tourette's Syndrome. Mov Disord Clin Pract 2019;6:40-5. [PMID: 30746414 DOI: 10.1002/mdc3.12696] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
473 Suhr JA, Cook C, Morgan B. Assessing Functional Impairment in ADHD: Concerns for Validity of Self-Report. Psychol Inj and Law 2017;10:151-60. [DOI: 10.1007/s12207-017-9292-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
474 Hughes GC, O'Hanrahan S, Kavanagh G, McNicholas F. Review of international clinical guidelines for adolescents on transition to Adult Mental Health Services and adults with attention-deficit hyperactivity disorder and their application to an irish context. Ir J Psychol Med 2017;34:59-73. [PMID: 30115162 DOI: 10.1017/ipm.2015.62] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
475 Young S, Sedgwick O, Fridman M, Gudjonsson G, Hodgkins P, Lantigua M, González RA. Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis. Psychol Med 2015;45:2499-510. [PMID: 25857258 DOI: 10.1017/S0033291715000598] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 6.1] [Reference Citation Analysis]
476 Hamzeloo M, Mashhadi A, Salehi Fadardi J. The Prevalence of ADHD and Comorbid Disorders in Iranian Adult Male Prison Inmates. J Atten Disord 2016;20:590-8. [DOI: 10.1177/1087054712457991] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
477 Reimherr FW, Marchant BK, Gift TE, Steans TA. ADHD and Anxiety: Clinical Significance and Treatment Implications. Curr Psychiatry Rep 2017;19. [DOI: 10.1007/s11920-017-0859-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
478 Biederman J, Fried R, Disalvo M, Woodworth KY, Biederman I, Noyes E, Faraone SV, Perlis RH. A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder. J Clin Psychopharmacol 2019;39:351-6. [DOI: 10.1097/jcp.0000000000001055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
479 Bordoff B. The Challenges and Limitations of Diagnosing and Pharmacologically Treating ADHD in University Students. Psychol Inj and Law 2017;10:114-20. [DOI: 10.1007/s12207-017-9288-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
480 Thomas M, Rostain A, Corso R, Babcock T, Madhoo M. ADHD in the College Setting: Current Perceptions and Future Vision. J Atten Disord 2015;19:643-54. [DOI: 10.1177/1087054714527789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
481 Childress AC. A critical appraisal of atomoxetine in the management of ADHD. Ther Clin Risk Manag 2016;12:27-39. [PMID: 26730199 DOI: 10.2147/TCRM.S59270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
482 Joseph HM, Kennedy TM, Gnagy EM, Perlman SB, Pelham WE Jr, Molina BSG. Fathers with Childhood ADHD, Parenting, and Their Young Children's Behavior: Offspring of the Pittsburgh ADHD Longitudinal Study (PALS). Child Psychiatry Hum Dev 2019;50:35-44. [PMID: 29872996 DOI: 10.1007/s10578-018-0819-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
483 Schmitz M, Polanczyk G, Rohde LAP. TDAH: remissão na adolescência e preditores de persistência em adultos. J bras psiquiatr 2007;56:25-9. [DOI: 10.1590/s0047-20852007000500006] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
484 dela Peña I, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH. Reinforcing effects of methamphetamine in an animal model of attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat. Behav Brain Funct 2010;6:72. [PMID: 21143898 DOI: 10.1186/1744-9081-6-72] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
485 Ramsay JR. “Without a Net”: CBT Without Medications for an Adult With ADHD. Clinical Case Studies 2012;11:48-65. [DOI: 10.1177/1534650112440741] [Cited by in Crossref: 10] [Article Influence: 1.0] [Reference Citation Analysis]
486 Mcgough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA. An Eight-week, Open-trial, Pilot Feasibility Study of Trigeminal Nerve Stimulation in Youth With Attention-deficit/Hyperactivity Disorder. Brain Stimulation 2015;8:299-304. [DOI: 10.1016/j.brs.2014.11.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
487 Gibbins C, Toplak ME, Flora DB, Weiss MD, Tannock R. Evidence for a general factor model of ADHD in adults. J Atten Disord 2012;16:635-44. [PMID: 22076604 DOI: 10.1177/1087054711416310] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
488 Sobanski E, Sabljic D, Alm B, Skopp G, Kettler N, Mattern R, Strohbeck-kühner P. Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD). J Neural Transm 2008;115:347-56. [DOI: 10.1007/s00702-007-0834-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
489 Pagoto S, Schneider K, Appelhans BM, Curtin C, Hajduk A. Psychological Co-morbidities of Obesity. In: Pagoto S, editor. Psychological Co-morbidities of Physical Illness. New York: Springer; 2011. pp. 1-72. [DOI: 10.1007/978-1-4419-0029-6_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
490 Guldberg-kjär T, Sehlin S, Johansson B. ADHD symptoms across the lifespan in a population-based Swedish sample aged 65 to 80. Int Psychogeriatr 2013;25:667-75. [DOI: 10.1017/s1041610212002050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
491 Robb A, Findling RL. Challenges in the transition of care for adolescents with attention-deficit/hyperactivity disorder. Postgrad Med 2013;125:131-40. [PMID: 23933901 DOI: 10.3810/pgm.2013.07.2685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
492 Shura RD, Miskey HM, Williams VG, Jadidian A, Rowland JA. Informing Evidence-Based Assessment of ADHD in Veterans and Service Members. Military Psychology 2017;29:27-40. [DOI: 10.1037/mil0000138] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
493 Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology 2018;88:105-14. [PMID: 29197795 DOI: 10.1016/j.psyneuen.2017.11.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
494 Volkow ND, Swanson JM. Clinical practice: Adult attention deficit-hyperactivity disorder. N Engl J Med 2013;369:1935-44. [PMID: 24224626 DOI: 10.1056/NEJMcp1212625] [Cited by in Crossref: 110] [Cited by in F6Publishing: 37] [Article Influence: 12.2] [Reference Citation Analysis]
495 Pettersson E, Anckarsäter H, Gillberg C, Lichtenstein P. Different neurodevelopmental symptoms have a common genetic etiology. J Child Psychol Psychiatry 2013;54:1356-65. [PMID: 24127638 DOI: 10.1111/jcpp.12113] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.9] [Reference Citation Analysis]
496 Carrellas N, Wilens TE, Anselmo R. Treatment of Comorbid Substance Use Disorders and ADHD in Youth. Curr Treat Options Psych 2016;3:15-27. [DOI: 10.1007/s40501-016-0072-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
497 Roberts W, Peters JR, Adams ZW, Lynam DR, Milich R. Identifying the facets of impulsivity that explain the relation between ADHD symptoms and substance use in a nonclinical sample. Addict Behav 2014;39:1272-7. [PMID: 24813555 DOI: 10.1016/j.addbeh.2014.04.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
498 Baumeister AA. Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson's Disease? Harv Rev Psychiatry 2021;29:142-58. [PMID: 33560690 DOI: 10.1097/HRP.0000000000000283] [Reference Citation Analysis]
499 Koyuncu A, Çelebi F, Ertekin E, Kök BE, Tükel R. Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series. Ther Adv Psychopharmacol 2017;7:241-7. [PMID: 29090087 DOI: 10.1177/2045125317714193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
500 Chen Q, Hartman CA, Haavik J, Harro J, Klungsøyr K, Hegvik TA, Wanders R, Ottosen C, Dalsgaard S, Faraone SV, Larsson H. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study. PLoS One 2018;13:e0204516. [PMID: 30256837 DOI: 10.1371/journal.pone.0204516] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
501 Kollins SH, Adcock RA. ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence. Prog Neuropsychopharmacol Biol Psychiatry 2014;52:70-8. [PMID: 24560930 DOI: 10.1016/j.pnpbp.2014.02.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
502 Liebrenz M, Hof D, Buadze A, Stohler R, Eich D. High dose methylphenidate treatment in adult attention deficit hyperactivity disorder: a case report. J Med Case Rep 2012;6:125. [PMID: 22583957 DOI: 10.1186/1752-1947-6-125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
503 Medori R, Ramos-quiroga JA, Casas M, Kooij J, Niemelä A, Trott G, Lee E, Buitelaar JK. A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry 2008;63:981-9. [DOI: 10.1016/j.biopsych.2007.11.008] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 8.6] [Reference Citation Analysis]
504 Bonvicini C, Faraone SV, Scassellati C. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. Mol Psychiatry 2016;21:872-84. [PMID: 27217152 DOI: 10.1038/mp.2016.74] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 15.3] [Reference Citation Analysis]
505 Williamson D, Johnston C. Gender differences in adults with attention-deficit/hyperactivity disorder: A narrative review. Clin Psychol Rev 2015;40:15-27. [PMID: 26046624 DOI: 10.1016/j.cpr.2015.05.005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
506 Uçar HN, Eray Ş, Vural AP, Kocael Ö. Perceived Family Climate and Self-Esteem in Adolescents With ADHD: A Study With a Control Group. J Atten Disord 2020;24:1132-40. [PMID: 28447908 DOI: 10.1177/1087054717696772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
507 Hammerness P, Surman C, Miller K. Update on adult attention-deficit/hyperactivity disorder. Curr Neurol Neurosci Rep 2008;8:484-9. [PMID: 18957185 DOI: 10.1007/s11910-008-0077-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
508 Litson K, Geiser C, Burns GL, Servera M. Trait and State Variance in Multi-Informant Assessments of ADHD and Academic Impairment in Spanish First-Grade Children. J Clin Child Adolesc Psychol 2018;47:699-712. [PMID: 26890535 DOI: 10.1080/15374416.2015.1118693] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
509 Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Res Neuroimaging 2017;269:36-42. [PMID: 28938219 DOI: 10.1016/j.pscychresns.2017.09.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
510 Mattingly GW, Young J. A clinician's guide for navigating the world of attention deficit hyperactivity disorder medications. CNS Spectr 2021;26:104-14. [PMID: 33541479 DOI: 10.1017/S1092852921000146] [Reference Citation Analysis]
511 Young JL, Sarkis E, Qiao M, Wietecha L. Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial. Clin Neuropharmacol 2011;34:51-60. [PMID: 21406998 DOI: 10.1097/WNF.0b013e31820c00eb] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
512 Fasmer OB, Riise T, Eagan TM, Lund A, Dilsaver SC, Hundal O, Oedegaard KJ. Comorbidity of asthma with ADHD. J Atten Disord 2011;15:564-71. [PMID: 20574059 DOI: 10.1177/1087054710372493] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
513 Momoda M, Yoshizaki A, Nagatani F, Nishimura T, Taniike M, Mohri I. Impaired executive function in junior high school students with excess sleep time. Vulnerable Children and Youth Studies 2019;14:116-28. [DOI: 10.1080/17450128.2019.1580404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
514 Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NL, Hale TS, Pataki C, Smalley SL. Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord. 2008;11:737-746. [PMID: 18025249 DOI: 10.1177/1087054707308502] [Cited by in Crossref: 373] [Cited by in F6Publishing: 261] [Article Influence: 24.9] [Reference Citation Analysis]
515 Pawaskar M, Fridman M, Grebla R, Madhoo M. Comparison of Quality of Life, Productivity, Functioning and Self-Esteem in Adults Diagnosed With ADHD and With Symptomatic ADHD. J Atten Disord 2020;24:136-44. [PMID: 31043096 DOI: 10.1177/1087054719841129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
516 Hook RW, Grant JE, Ioannidis K, Tiego J, Yücel M, Wilkinson P, Chamberlain SR. Trans-diagnostic measurement of impulsivity and compulsivity: A review of self-report tools. Neurosci Biobehav Rev 2021;120:455-69. [PMID: 33115636 DOI: 10.1016/j.neubiorev.2020.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
517 Mccarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong ICK. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009;194:273-7. [DOI: 10.1192/bjp.bp.107.045245] [Cited by in Crossref: 138] [Cited by in F6Publishing: 96] [Article Influence: 34.5] [Reference Citation Analysis]
518 van der Marel K, Bouet V, Meerhoff G, Freret T, Boulouard M, Dauphin F, Klomp A, Lucassen P, Homberg J, Dijkhuizen R, Reneman L. Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. Neuroscience 2015;309:243-58. [DOI: 10.1016/j.neuroscience.2015.04.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
519 Corbisiero S, Buchli-kammermann J, Stieglitz R. Reliabilität und Validität des Wender-Reimherr-Interviews (WRI): Ein Instrument zur Diagnostik der ADHS im Erwachsenenalter. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2010;58:323-31. [DOI: 10.1024/1661-4747/a000043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
520 Marcus DK, Norris AL, Coccaro EF. The latent structure of attention deficit/hyperactivity disorder in an adult sample. J Psychiatr Res 2012;46:782-9. [PMID: 22480749 DOI: 10.1016/j.jpsychires.2012.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
521 Lahey BB, Zald DH, Perkins SF, Villalta-Gil V, Werts KB, Van Hulle CA, Rathouz PJ, Applegate B, Class QA, Poore HE, Watts AL, Waldman ID. Measuring the hierarchical general factor model of psychopathology in young adults. Int J Methods Psychiatr Res 2018;27. [PMID: 28990308 DOI: 10.1002/mpr.1593] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
522 Zhang KA, Markon KE. Age and Gender Measurement Noninvariance of the Adult ADHD Self-Report Scale Screener. J Atten Disord 2021;25:403-13. [PMID: 30449230 DOI: 10.1177/1087054718808059] [Reference Citation Analysis]
523 Callahan BL, Bierstone D, Stuss DT, Black SE. Adult ADHD: Risk Factor for Dementia or Phenotypic Mimic? Front Aging Neurosci 2017;9:260. [PMID: 28824421 DOI: 10.3389/fnagi.2017.00260] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
524 Barbaresi WJ, Weaver AL, Voigt RG, Killian JM, Katusic SK. Comparing Methods to Determine Persistence of Childhood ADHD Into Adulthood: A Prospective, Population-Based Study. J Atten Disord 2018;22:571-80. [PMID: 26700793 DOI: 10.1177/1087054715618791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
525 Loya JM, McCauley KL, Chronis-Tuscano A, Chen SZ, Gad A, MacPherson L, Lejuez CW. An experimental paradigm examining the influence of frustration on risk-taking behavior. Behav Processes 2019;158:155-62. [PMID: 30366109 DOI: 10.1016/j.beproc.2018.10.013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
526 Wigal T, Brams M, Gasior M, Gao J, Giblin J. Effect size of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Postgrad Med 2011;123:169-76. [PMID: 21474905 DOI: 10.3810/pgm.2011.03.2275] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
527 Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry 2006;59:1065-70. [PMID: 16499880 DOI: 10.1016/j.biopsych.2005.10.029] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
528 Lit L, Schweitzer JB, Iosif AM, Oberbauer AM. Owner reports of attention, activity, and impulsivity in dogs: a replication study. Behav Brain Funct 2010;6:1. [PMID: 20047681 DOI: 10.1186/1744-9081-6-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
529 O’callaghan P, Sharma D. Severity of Symptoms and Quality of Life in Medical Students With ADHD. J Atten Disord 2014;18:654-8. [DOI: 10.1177/1087054712445064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
530 Zamboni L, Marchetti P, Congiu A, Giordano R, Fusina F, Carli S, Centoni F, Verlato G, Lugoboni F. ASRS Questionnaire and Tobacco Use: Not Just a Cigarette. A Screening Study in an Italian Young Adult Sample. Int J Environ Res Public Health 2021;18:2920. [PMID: 33809225 DOI: 10.3390/ijerph18062920] [Reference Citation Analysis]
531 Aduen PA, Kofler MJ, Sarver DE, Wells EL, Soto EF, Cox DJ. ADHD, depression, and motor vehicle crashes: A prospective cohort study of continuously-monitored, real-world driving. J Psychiatr Res 2018;101:42-9. [PMID: 29547761 DOI: 10.1016/j.jpsychires.2018.02.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
532 Gabriel A. The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study. Atten Defic Hyperact Disord 2010;2:87-92. [PMID: 21432593 DOI: 10.1007/s12402-010-0025-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
533 De la Torre-Iturbe S, Vázquez-Roque RA, De la Cruz-López F, Flores G, Garcés-Ramírez L. Dendritic and behavioral changes in rats neonatally treated with homocysteine; A proposal as an animal model to study the attention deficit hyperactivity disorder. J Chem Neuroanat 2022;119:102057. [PMID: 34871732 DOI: 10.1016/j.jchemneu.2021.102057] [Reference Citation Analysis]
534 Hsu NS, Novick JM, Jaeggi SM. The development and malleability of executive control abilities. Front Behav Neurosci 2014;8:221. [PMID: 25071485 DOI: 10.3389/fnbeh.2014.00221] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
535 Castagna PJ, Roye S, Calamia M. The Compensatory ADHD Behaviors Scale (CABS): Development and Initial Validation. Assessment 2019;26:783-98. [PMID: 29754497 DOI: 10.1177/1073191118774841] [Reference Citation Analysis]
536 Gümüş YY, Çakin Memik N, Ağaoğlu B. Anxiety Disorders Comorbidity in Children and Adolescents with Attention Deficit Hyperactivity Disorder. Noro Psikiyatr Ars 2015;52:185-93. [PMID: 28360702 DOI: 10.5152/npa.2015.7024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
537 Bolden LB, Griffis JC, Nenert R, Allendorfer JB, Szaflarski JP. Cortical excitability affects mood state in patients with idiopathic generalized epilepsies (IGEs). Epilepsy Behav 2019;90:84-9. [PMID: 30517908 DOI: 10.1016/j.yebeh.2018.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
538 Wang XH, Li L. Altered temporal features of intrinsic connectivity networks in boys with combined type of attention deficit hyperactivity disorder. Eur J Radiol 2015;84:947-54. [PMID: 25795197 DOI: 10.1016/j.ejrad.2015.02.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
539 Asherson P, Bushe C, Saylor K, Tanaka Y, Deberdt W, Upadhyaya H. Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trials. J Psychopharmacol 2014;28:837-46. [PMID: 25035246 DOI: 10.1177/0269881114542453] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
540 Agoalikum E, Klugah-Brown B, Yang H, Wang P, Varshney S, Niu B, Biswal B. Differences in Disrupted Dynamic Functional Network Connectivity Among Children, Adolescents, and Adults With Attention Deficit/Hyperactivity Disorder: A Resting-State fMRI Study. Front Hum Neurosci 2021;15:697696. [PMID: 34675790 DOI: 10.3389/fnhum.2021.697696] [Reference Citation Analysis]
541 White HA, Shah P. Scope of Semantic Activation and Innovative Thinking in College Students with ADHD. Creativity Research Journal 2016;28:275-82. [DOI: 10.1080/10400419.2016.1195655] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
542 Psychogiou L, Daley DM, Thompson MJ, Sonuga-barke EJS. Do maternal attention-deficit/hyperactivity disorder symptoms exacerbate or ameliorate the negative effect of child attention-deficit/hyperactivity disorder symptoms on parenting? Dev Psychopathol 2008;20:121-37. [DOI: 10.1017/s0954579408000060] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
543 Inoue Y, Howard AG, Stickley A, Yazawa A, Gordon-Larsen P. Sex and racial/ethnic differences in the association between childhood attention-deficit/hyperactivity disorder symptom subtypes and body mass index in the transition from adolescence to adulthood in the United States. Pediatr Obes 2019;14:e12498. [PMID: 30629806 DOI: 10.1111/ijpo.12498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
544 Walsh RFL, Sheppard B, Cui L, Brown C, Van Meter A, Merikangas KR. Comorbidity and patterns of familial aggregation in attention-deficit/hyperactivity disorder and bipolar disorder in a family study of affective and anxiety spectrum disorders. J Psychiatr Res 2020;130:355-61. [PMID: 32882577 DOI: 10.1016/j.jpsychires.2020.08.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
545 Nichols JQVA, Shoulberg EK, Garner AA, Hoza B, Burt KB, Murray-close D, Arnold LE. Exploration of the Factor Structure of ADHD in Adolescence through Self, Parent, and Teacher Reports of Symptomatology. J Abnorm Child Psychol 2017;45:625-41. [DOI: 10.1007/s10802-016-0183-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
546 Clemow DB, Mason OW, Sarkis EH, Ruff DD, Berman BD, Donnelly CL, Robb AS, Holland DS, Schuh KJ, Barnes JM, Araujo AB. Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study. Expert Review of Neurotherapeutics 2015;15:1353-66. [DOI: 10.1586/14737175.2015.1102060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
547 Wilens TE, Adler LA, Tanaka Y, Xiao F, D'Souza DN, Gutkin SW, Upadhyaya HP. Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin 2011;27:2309-20. [PMID: 22029549 DOI: 10.1185/03007995.2011.628648] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
548 Shen Y, Chan BSM, Liu J, Meng F, Yang T, He Y, Lu J, Luo X, Zhang XY. Estimated prevalence and associated risk factors of attention deficit hyperactivity disorder (ADHD) among medical college students in a Chinese population. J Affect Disord 2018;241:291-6. [PMID: 30142587 DOI: 10.1016/j.jad.2018.08.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
549 Kowalyk TV, Davis C, Wattie N, Baker J. No link between date of birth and ADHD symptoms in adults. J Atten Disord 2014;18:73-81. [PMID: 22628146 DOI: 10.1177/1087054712445063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
550 Hong M, Lee WH, Moon DS, Lee SM, Chung US, Bahn GH. A 36 month naturalistic retrospective study of clinic-treated youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2014;24:341-6. [PMID: 24955936 DOI: 10.1089/cap.2013.0090] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
551 Bolden J. Associations Among Attention Problems, Learning Strategies, and Hazardous Drinking Behavior in a College Student Sample: A Pilot Study. Subst Abuse 2019;13:1178221819848356. [PMID: 31190852 DOI: 10.1177/1178221819848356] [Reference Citation Analysis]
552 Merkt J, Gawrilow C. Health, Dietary Habits, and Achievement Motivation in College Students With Self-Reported ADHD Diagnosis. J Atten Disord 2016;20:727-40. [DOI: 10.1177/1087054714523127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
553 Morin AJ, Tran A, Caci H. Factorial Validity of the ADHD Adult Symptom Rating Scale in a French Community Sample: Results From the ChiP-ARD Study. J Atten Disord 2016;20:530-41. [PMID: 23729493 DOI: 10.1177/1087054713488825] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
554 Biederman J, Petty CR, Fried R, Fontanella J, Doyle AE, Seidman LJ, Faraone SV. Can self-reported behavioral scales assess executive function deficits? A controlled study of adults with ADHD. J Nerv Ment Dis 2007;195:240-6. [PMID: 17468684 DOI: 10.1097/01.nmd.0000243968.06789.73] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
555 Callahan BL, Plamondon A. Examining the validity of the ADHD concept in adults and older adults. CNS Spectr 2019;24:518-25. [DOI: 10.1017/s1092852918001190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
556 Morissette MP, Prior HJ, Tate RB, Wade J, Leiter JRS. Associations between concussion and risk of diagnosis of psychological and neurological disorders: a retrospective population-based cohort study. Fam Med Community Health 2020;8:e000390. [PMID: 32719017 DOI: 10.1136/fmch-2020-000390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
557 Nankoo MMA, Palermo R, Bell JA, Pestell CM. Examining the Rate of Self-Reported ADHD-Related Traits and Endorsement of Depression, Anxiety, Stress, and Autistic-Like Traits in Australian University Students. J Atten Disord 2019;23:869-86. [DOI: 10.1177/1087054718758901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
558 Eklund H, Cadman T, Findon J, Hayward H, Howley D, Beecham J, Xenitidis K, Murphy D, Asherson P, Glaser K. Clinical service use as people with Attention Deficit Hyperactivity Disorder transition into adolescence and adulthood: a prospective longitudinal study. BMC Health Serv Res 2016;16:248. [PMID: 27400778 DOI: 10.1186/s12913-016-1509-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
559 Alperin BR, Christoff K, Mills C, Karalunas SL. More than off-task: Increased freely-moving thought in ADHD. Conscious Cogn 2021;93:103156. [PMID: 34119895 DOI: 10.1016/j.concog.2021.103156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
560 McIntosh D, Kutcher S, Binder C, Levitt A, Fallu A, Rosenbluth M. Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD. Neuropsychiatr Dis Treat 2009;5:137-50. [PMID: 19557108 DOI: 10.2147/ndt.s4720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 0.2] [Reference Citation Analysis]
561 Meijer WM, Faber A, van den Ban E, Tobi H. Current issues around the pharmacotherapy of ADHD in children and adults. Pharm World Sci 2009;31:509-16. [PMID: 19562500 DOI: 10.1007/s11096-009-9302-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
562 Sambrani T, Jakubovski E, Müller-Vahl KR. New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center. Front Neurosci 2016;10:415. [PMID: 27672357 DOI: 10.3389/fnins.2016.00415] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
563 Knight LA, Rooney M, Chronis-Tuscano A. Psychosocial treatments for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2008;10:412-8. [PMID: 18803915 DOI: 10.1007/s11920-008-0066-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
564 Abbott D, Shirali Y, Haws JK, Lack CW. Biobehavioral assessment of the anxiety disorders: Current progress and future directions. World J Psychiatr 2017; 7(3): 133-147 [PMID: 29043151 DOI: 10.5498/wjp.v7.i3.133] [Cited by in CrossRef: 2] [Article Influence: 0.4] [Reference Citation Analysis]
565 Staller JA, Faraone SV. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics 2014;7:351-62. [DOI: 10.1586/14737175.7.4.351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
566 Biederman J, Ball SW, Monuteaux MC, Mick E, Spencer TJ, Mccreary M, Cote M, Faraone SV. New Insights Into the Comorbidity Between ADHD and Major Depression in Adolescent and Young Adult Females. Journal of the American Academy of Child & Adolescent Psychiatry 2008;47:426-34. [DOI: 10.1097/chi.0b013e31816429d3] [Cited by in Crossref: 178] [Cited by in F6Publishing: 79] [Article Influence: 12.7] [Reference Citation Analysis]
567 Davidson J, Zhang W, Connor K, Ji J, Jobson K, Lecrubier Y, Mcfarlane A, Newport D, Nutt D, Osser D, Stein D, Stowe Z, Tajima O, Versiani M. Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). J Psychopharmacol 2010;24:3-26. [DOI: 10.1177/0269881108096505] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
568 Caci H, Asherson P, Donfrancesco R, Faraone SV, Hervas A, Fitzgerald M, Döpfner M. Daily life impairments associated with childhood/adolescent attention-deficit/hyperactivity disorder as recalled by adults: results from the European Lifetime Impairment Survey. CNS Spectr 2015;20:112-21. [PMID: 24571924 DOI: 10.1017/S1092852914000078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
569 Chen VC, Hsu TC, Chen LJ, Chou HC, Weng JC, Tzang BS. Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats. PLoS One 2017;12:e0181122. [PMID: 28700674 DOI: 10.1371/journal.pone.0181122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
570 Robb AS, Findling RL, Childress AC, Berry SA, Belden HW, Wigal SB. Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD. J Atten Disord 2017;21:1180-91. [PMID: 24874348 DOI: 10.1177/1087054714533191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
571 Sibley MH. Empirically-informed guidelines for first-time adult ADHD diagnosis. J Clin Exp Neuropsychol 2021;43:340-51. [PMID: 33949916 DOI: 10.1080/13803395.2021.1923665] [Reference Citation Analysis]
572 Martel MM, Nigg JT, Schimmack U. Psychometrically Informed Approach to Integration of Multiple Informant Ratings in Adult ADHD in a Community-Recruited Sample. Assessment 2017;24:279-89. [PMID: 27126924 DOI: 10.1177/1073191116646443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
573 Vogel SW, ten Have M, Bijlenga D, de Graaf R, Beekman AT, Kooij JS. Distribution of ADHD symptoms, and associated comorbidity, exposure to risk factors and disability: Results from a general population study. Psychiatry Research 2018;267:256-65. [DOI: 10.1016/j.psychres.2018.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
574 Richard-lepouriel H, Etain B, Hasler R, Bellivier F, Gard S, Kahn J, Prada P, Nicastro R, Ardu S, Dayer A, Leboyer M, Aubry J, Perroud N, Henry C. Similarities between emotional dysregulation in adults suffering from ADHD and bipolar patients. Journal of Affective Disorders 2016;198:230-6. [DOI: 10.1016/j.jad.2016.03.047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
575 Cassidy TA, Varughese S, Russo L, Budman SH, Eaton TA, Butler SF. Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet Survey. J Atten Disord 2015;19:630-40. [PMID: 23269194 DOI: 10.1177/1087054712468486] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
576 Xenaki L, Pehlivanidis A. Clinical, neuropsychological and structural convergences and divergences between Attention Deficit/Hyperactivity Disorder and Borderline Personality Disorder: A systematic review. Personality and Individual Differences 2015;86:438-49. [DOI: 10.1016/j.paid.2015.06.049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
577 Kambeitz J, Romanos M, Ettinger U. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD. Pharmacogenomics J 2014;14:77-84. [PMID: 23588108 DOI: 10.1038/tpj.2013.9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
578 Tarrant N, Roy M, Deb S, Odedra S, Retzer A, Roy A. The effectiveness of methylphenidate in the management of Attention Deficit Hyperactivity Disorder (ADHD) in people with intellectual disabilities: A systematic review. Res Dev Disabil 2018;83:217-32. [PMID: 30266025 DOI: 10.1016/j.ridd.2018.08.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
579 Pinna M, Visioli C, Rago CM, Manchia M, Tondo L, Baldessarini RJ. Attention deficit-hyperactivity disorder in adult bipolar disorder patients. J Affect Disord 2019;243:391-6. [PMID: 30267955 DOI: 10.1016/j.jad.2018.09.038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
580 Michielsen M, Semeijn E, Comijs HC, van de Ven P, Beekman ATF, Deeg DJH, Kooij JJS. Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands. Br J Psychiatry 2012;201:298-305. [DOI: 10.1192/bjp.bp.111.101196] [Cited by in Crossref: 110] [Cited by in F6Publishing: 76] [Article Influence: 27.5] [Reference Citation Analysis]
581 Clemow DB, Walker DJ. The Potential for Misuse and Abuse of Medications in ADHD: A Review. Postgraduate Medicine 2015;126:64-81. [DOI: 10.3810/pgm.2014.09.2801] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
582 Babcock T, Ornstein CS. Comorbidity and its Impact in Adult Patients with Attention-Deficit/Hyperactivity Disorder: A Primary Care Perspective. Postgraduate Medicine 2015;121:73-82. [DOI: 10.3810/pgm.2009.05.2005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
583 Ivanchak N, Fletcher K, Jicha GA. Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment. Curr Psychiatry Rep 2012;14:552-60. [PMID: 22886581 DOI: 10.1007/s11920-012-0305-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
584 Schoenfelder EN, Faraone SV, Kollins SH. Stimulant treatment of ADHD and cigarette smoking: a meta-analysis. Pediatrics 2014;133:1070-80. [PMID: 24819571 DOI: 10.1542/peds.2014-0179] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
585 Aduen PA, Kofler MJ, Cox DJ, Sarver DE, Lunsford E. Motor vehicle driving in high incidence psychiatric disability: comparison of drivers with ADHD, depression, and no known psychopathology. J Psychiatr Res 2015;64:59-66. [PMID: 25843156 DOI: 10.1016/j.jpsychires.2015.03.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
586 Weisler RH. Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder. Expert Opin Pharmacother 2007;8:745-58. [PMID: 17425471 DOI: 10.1517/14656566.8.6.745] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
587 Seo JY, Lee CS, Park CS, Kim BJ, Cha BS, Lee SJ, Ahn IY. Mediating Effect of Depressive Symptoms on the Relationship between Adult Attention Deficit Hyperactivity Disorder and Quality of Life. Psychiatry Investig 2014;11:131-6. [PMID: 24843367 DOI: 10.4306/pi.2014.11.2.131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
588 Bondü R, Esser G. Justice and rejection sensitivity in children and adolescents with ADHD symptoms. Eur Child Adolesc Psychiatry 2015;24:185-98. [DOI: 10.1007/s00787-014-0560-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
589 Torralva T, Gleichgerrcht E, Torrente F, Roca M, Strejilevich SA, Cetkovich M, Lischinsky A, Manes F. Neuropsychological functioning in adult bipolar disorder and ADHD patients: a comparative study. Psychiatry Res 2011;186:261-6. [PMID: 20832868 DOI: 10.1016/j.psychres.2010.08.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
590 Yang HN, Tai YM, Yang LK, Gau SS. Prediction of childhood ADHD symptoms to quality of life in young adults: adult ADHD and anxiety/depression as mediators. Res Dev Disabil 2013;34:3168-81. [PMID: 23886759 DOI: 10.1016/j.ridd.2013.06.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
591 Brown A, Biederman J, Valera E, Lomedico A, Aleardi M, Makris N, Seidman LJ. Working memory network alterations and associated symptoms in adults with ADHD and Bipolar Disorder. J Psychiatr Res 2012;46:476-83. [PMID: 22272986 DOI: 10.1016/j.jpsychires.2012.01.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
592 Murray AL, Wong SC, Obsuth I, Rhodes S, Eisner M, Ribeaud D. An ecological momentary assessment study of the role of emotional dysregulation in co-occurring ADHD and internalising symptoms in adulthood. J Affect Disord 2021;281:708-13. [PMID: 33234281 DOI: 10.1016/j.jad.2020.11.086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
593 Edvinsson D, Bingefors K, Lindström E, Lewander T. ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Ups J Med Sci 2010;115:30-40. [PMID: 20085506 DOI: 10.3109/03009730903532333] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
594 Knop J, Penick EC, Nickel EJ, Mortensen EL, Sullivan MA, Murtaza S, Jensen P, Manzardo AM, Gabrielli WF Jr. Childhood ADHD and conduct disorder as independent predictors of male alcohol dependence at age 40. J Stud Alcohol Drugs 2009;70:169-77. [PMID: 19261228 DOI: 10.15288/jsad.2009.70.169] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
595 Ashinoff BK, Abu-Akel A. Hyperfocus: the forgotten frontier of attention. Psychol Res 2021;85:1-19. [PMID: 31541305 DOI: 10.1007/s00426-019-01245-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
596 Anker E, Bendiksen B, Heir T. Comorbid psychiatric disorders in a clinical sample of adults with ADHD, and associations with education, work and social characteristics: a cross-sectional study. BMJ Open 2018;8:e019700. [PMID: 29500213 DOI: 10.1136/bmjopen-2017-019700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
597 Umeda M, Shimoda H, Miyamoto K, Ishikawa H, Tachimori H, Takeshima T, Kawakami N. Comorbidity and sociodemographic characteristics of adult autism spectrum disorder and attention deficit hyperactivity disorder: epidemiological investigation in the World Mental Health Japan 2nd Survey. Int J Dev Disabil 2019;67:58-66. [PMID: 34141399 DOI: 10.1080/20473869.2019.1576409] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
598 Faison SL, Fry N, Adewole T, Odebo O, Wang Z, Maletic V, Nasser A. Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. J Clin Psychopharmacol 2021;41:155-62. [PMID: 33587403 DOI: 10.1097/JCP.0000000000001361] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
599 Bolea-alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, Heal D, Müller U, Nash J, Santosh P, Sayal K, Sonuga-barke E, Young SJ; for the Consensus Group. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2014;28:179-203. [DOI: 10.1177/0269881113519509] [Cited by in Crossref: 157] [Cited by in F6Publishing: 132] [Article Influence: 19.6] [Reference Citation Analysis]
600 Syrstad VEG, Oedegaard KJ, Fasmer OB, Halmoy A, Haavik J, Dilsaver S, Gjestad R. Cyclothymic temperament: Associations with ADHD, other psychopathology, and medical morbidity in the general population. J Affect Disord 2020;260:440-7. [PMID: 31539678 DOI: 10.1016/j.jad.2019.08.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
601 Capusan AJ, Bendtsen P, Marteinsdottir I, Kuja-Halkola R, Larsson H. Genetic and environmental contributions to the association between attention deficit hyperactivity disorder and alcohol dependence in adulthood: A large population-based twin study. Am J Med Genet B Neuropsychiatr Genet 2015;168:414-22. [PMID: 25711682 DOI: 10.1002/ajmg.b.32300] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
602 Evren C, Cicekci E, Umut G, Evren B, Durmus Cicek K. The Mediating Effects of Self-Esteem and Harm Avoidance on the Association between Social Anxiety Symptoms and Adult Attention Deficit Hyperactivity Disorder Symptom Severity in Turkish Inpatients with Alcohol Use Disorder. Iran J Psychiatry 2021;16:281-9. [PMID: 34616461 DOI: 10.18502/ijps.v16i3.6253] [Reference Citation Analysis]
603 Zhu HJ, Patrick KS, Straughn AB, Reeves OT 3rd, Bernstein H, Shi J, Johnson HJ, Knight JM, Smith AT, Malcolm RJ, Markowitz JS. Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. J Clin Psychopharmacol 2017;37:419-28. [PMID: 28590363 DOI: 10.1097/JCP.0000000000000721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
604 Oedegaard KJ, Greenwood TA, Johansson S, Jacobsen KK, Halmoy A, Fasmer OB, Akiskal HS, Haavik J, Kelsoe JR; Bipolar Genome Study (BiGS). A genome-wide association study of bipolar disorder and comorbid migraine. Genes Brain Behav 2010;9:673-80. [PMID: 20528957 DOI: 10.1111/j.1601-183X.2010.00601.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
605 Stickley A, Koyanagi A, Takahashi H, Ruchkin V, Inoue Y, Yazawa A, Kamio Y. Attention-deficit/hyperactivity disorder symptoms and happiness among adults in the general population. Psychiatry Research 2018;265:317-23. [DOI: 10.1016/j.psychres.2018.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
606 Schneider BC, Thoering T, Cludius B, Moritz S. Self-Reported Symptoms of Attention-Deficit/Hyperactivity Disorder: Rate of Endorsement and Association with Neuropsychological Performance in an Adult Psychiatric Sample. Archives of Clinical Neuropsychology 2015;30:186-91. [DOI: 10.1093/arclin/acv015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
607 Scholtissen-in de Braek DMJM, Hurks PPM, van Boxtel MPJ, Dijkstra JB, Jolles J. The Identification of Attention Complaints in the General Population and Their Effect on Quality of Life. J Atten Disord 2011;15:46-55. [DOI: 10.1177/1087054709347260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
608 Pozzi M, Carnovale C, Mazhar F, Peeters GG, Gentili M, Nobile M, Radice S, Clementi E. Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database. J Clin Psychopharmacol 2019;39:386-92. [DOI: 10.1097/jcp.0000000000001058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
609 Antai-Otong D. The art of prescribing pharmacological management of adult ADHD: implications for psychiatric care. Perspect Psychiatr Care 2008;44:196-201. [PMID: 18577125 DOI: 10.1111/j.1744-6163.2008.00174.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
610 Guan Lim C, Lim-Ashworth NSJ, Fung DSS. Updates in technology-based interventions for attention deficit hyperactivity disorder. Curr Opin Psychiatry 2020;33:577-85. [PMID: 32858596 DOI: 10.1097/YCO.0000000000000643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
611 Kedem S, Yust-Katz S, Carter D, Levi Z, Kedem R, Dickstein A, Daher S, Katz LH. Attention deficit hyperactivity disorder and gastrointestinal morbidity in a large cohort of young adults. World J Gastroenterol 2020; 26(42): 6626-6637 [PMID: 33268951 DOI: 10.3748/wjg.v26.i42.6626] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
612 Kajitani K, Tsuchimoto R, Omodaka Y, Matsushita T, Fukumori H, Sato T, Nagano J. Neurodevelopmental Disorder Traits in Taijin-Kyofu-sho and Social Anxiety Disorder: A Cross-Sectional Study among University Students. Psychiatry J 2021;2021:1661617. [PMID: 34568483 DOI: 10.1155/2021/1661617] [Reference Citation Analysis]
613 Angold A, Jane Costello E. Nosology and measurement in child and adolescent psychiatry. Journal of Child Psychology and Psychiatry 2009;50:9-15. [DOI: 10.1111/j.1469-7610.2008.01981.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
614 Valvassori SS, Frey BN, Martins MR, Réus GZ, Schimidtz F, Inácio CG, Kapczinski F, Quevedo J. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behav Pharmacol 2007;18:205-12. [PMID: 17426484 DOI: 10.1097/FBP.0b013e328153daf5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
615 Posner J, Park C, Wang Z. Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder. Neuropsychol Rev 2014;24:3-15. [PMID: 24496902 DOI: 10.1007/s11065-014-9251-z] [Cited by in Crossref: 137] [Cited by in F6Publishing: 125] [Article Influence: 17.1] [Reference Citation Analysis]
616 Solberg BS, Zayats T, Posserud MB, Halmøy A, Engeland A, Haavik J, Klungsøyr K. Patterns of Psychiatric Comorbidity and Genetic Correlations Provide New Insights Into Differences Between Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. Biol Psychiatry 2019;86:587-98. [PMID: 31182215 DOI: 10.1016/j.biopsych.2019.04.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
617 Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol 2010;25:157-73. [PMID: 20197297 DOI: 10.1093/arclin/acq014] [Cited by in Crossref: 241] [Cited by in F6Publishing: 194] [Article Influence: 20.1] [Reference Citation Analysis]
618 Liebrenz M, Frei A, Fisher CE, Gamma A, Buadze A, Eich D. Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions. BMC Psychiatry 2014;14:141. [PMID: 24885526 DOI: 10.1186/1471-244X-14-141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
619 Peasgood T, Bhardwaj A, Brazier JE, Biggs K, Coghill D, Daley D, Cooper CL, De Silva C, Harpin V, Hodgkins P, Nadkarni A, Setyawan J, Sonuga-Barke EJS. What Is the Health and Well-Being Burden for Parents Living With a Child With ADHD in the United Kingdom? J Atten Disord 2021;25:1962-76. [PMID: 32552265 DOI: 10.1177/1087054720925899] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
620 Nylander L, Holmqvist M, Gustafson L, Gillberg C. Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in adult psychiatry. A 20-year register study. Nordic Journal of Psychiatry 2012;67:344-50. [DOI: 10.3109/08039488.2012.748824] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
621 Wong IYT, Hawes DJ, Dar-Nimrod I. Illness representations among adolescents with attention deficit hyperactivity disorder: associations with quality of life, coping, and treatment adherence. Heliyon 2019;5:e02705. [PMID: 31687524 DOI: 10.1016/j.heliyon.2019.e02705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
622 Babcock T, Dirks B, Adeyi B, Scheckner B. Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study. BMC Pharmacol Toxicol 2012;13:18. [PMID: 23254273 DOI: 10.1186/2050-6511-13-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
623 Tibu F, Sheridan MA, McLaughlin KA, Nelson CA, Fox NA, Zeanah CH. Disruptions of working memory and inhibition mediate the association between exposure to institutionalization and symptoms of attention deficit hyperactivity disorder. Psychol Med 2016;46:529-41. [PMID: 26470598 DOI: 10.1017/S0033291715002020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
624 Young S, Amarasinghe JM. Practitioner review: Non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry 2010;51:116-33. [PMID: 19891745 DOI: 10.1111/j.1469-7610.2009.02191.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
625 Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 2009;26:212-21. [PMID: 19194995 DOI: 10.1002/da.20549] [Cited by in Crossref: 99] [Cited by in F6Publishing: 76] [Article Influence: 7.6] [Reference Citation Analysis]
626 Matthies S, Philipsen A, Lackner HK, Sadohara C, Svaldi J. Regulation of sadness via acceptance or suppression in adult Attention Deficit Hyperactivity Disorder (ADHD). Psychiatry Res 2014;220:461-7. [PMID: 25085791 DOI: 10.1016/j.psychres.2014.07.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
627 Joseph A, Kosmas CE, Patel C, Doll H, Asherson P. Health-Related Quality of Life and Work Productivity of Adults With ADHD: A U.K. Web-Based Cross-Sectional Survey. J Atten Disord 2019;23:1610-23. [PMID: 30215265 DOI: 10.1177/1087054718799367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
628 Park JL, Johnston C. Mothers’ Attributions for Positive and Negative Child Behavior: Associations With Mothers’ ADHD Symptoms. J Atten Disord 2019;23:475-86. [DOI: 10.1177/1087054716669590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
629 Bron T, Bijlenga D, Kooij J, Vogel S, Wynchank D, Beekman A, Penninx B. Attention-deficit hyperactivity disorder symptoms add risk to circadian rhythm sleep problems in depression and anxiety. Journal of Affective Disorders 2016;200:74-81. [DOI: 10.1016/j.jad.2016.04.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
630 Halmøy A, Klungsøyr K, Skjærven R, Haavik J. Pre- and perinatal risk factors in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2012;71:474-81. [PMID: 22200325 DOI: 10.1016/j.biopsych.2011.11.013] [Cited by in Crossref: 100] [Cited by in F6Publishing: 97] [Article Influence: 9.1] [Reference Citation Analysis]
631 Depue BE, Burgess GC, Bidwell LC, Willcutt EG, Banich MT. Behavioral performance predicts grey matter reductions in the right inferior frontal gyrus in young adults with combined type ADHD. Psychiatry Res 2010;182:231-7. [PMID: 20493669 DOI: 10.1016/j.pscychresns.2010.01.012] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
632 Bidwell LC, McClernon FJ, Kollins SH. Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav. 2011;99:262-274. [PMID: 21596055 DOI: 10.1016/j.pbb.2011.05.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
633 Sobanski E, Schredl M, Kettler N, Alm B. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 2008;31:375-81. [PMID: 18363314 DOI: 10.1093/sleep/31.3.375] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 6.9] [Reference Citation Analysis]
634 Surman CB, Hammerness PG, Pion K, Faraone SV. Do stimulants improve functioning in adults with ADHD? European Neuropsychopharmacology 2013;23:528-33. [DOI: 10.1016/j.euroneuro.2012.02.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
635 Murray AL, Caye A, McKenzie K, Auyeung B, Murray G, Ribeaud D, Freeston M, Eisner M. Reciprocal Developmental Relations Between ADHD and Anxiety in Adolescence: A Within-Person Longitudinal Analysis of Commonly Co-Occurring Symptoms. J Atten Disord 2022;26:109-18. [PMID: 32172640 DOI: 10.1177/1087054720908333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
636 Krueger RF, Bezdjian S. Enhancing research and treatment of mental disorders with dimensional concepts: toward DSM-V and ICD-11. World Psychiatry 2009;8:3-6. [PMID: 19293948 DOI: 10.1002/j.2051-5545.2009.tb00197.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
637 Mattos P, Louzã MR, Palmini AL, de Oliveira IR, Rocha FL. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study. J Atten Disord 2013;17:444-8. [PMID: 22334621 DOI: 10.1177/1087054711434772] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
638 Durell T, Adler L, Wilens T, Paczkowski M, Schuh K. Atomoxetine Treatment for ADHD: Younger Adults Compared With Older Adults. J Atten Disord 2010;13:401-6. [DOI: 10.1177/1087054709342203] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
639 Moreno-alcázar A, Ramos-quiroga JA, Radua J, Salavert J, Palomar G, Bosch R, Salvador R, Blanch J, Casas M, Mckenna PJ, Pomarol-clotet E. Brain abnormalities in adults with Attention Deficit Hyperactivity Disorder revealed by voxel-based morphometry. Psychiatry Research: Neuroimaging 2016;254:41-7. [DOI: 10.1016/j.pscychresns.2016.06.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
640 Connor DF, Ford JD, Chapman JF, Banga A. Adolescent Attention Deficit Hyperactivity Disorder in the Secure Treatment Setting. Criminal Justice and Behavior 2012;39:725-47. [DOI: 10.1177/0093854812437015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
641 Fijal BA, Guo Y, Li SG, Ahl J, Goto T, Tanaka Y, Nisenbaum LK, Upadhyaya HP. CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial. J Clin Pharmacol 2015;55:1167-74. [PMID: 25919121 DOI: 10.1002/jcph.530] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
642 Perry BA, Archer KR, Song Y, Ma Y, Green JK, Elefteriou F, Dahir KM. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study. Osteoporos Int 2016;27:2223-7. [PMID: 26928186 DOI: 10.1007/s00198-016-3547-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
643 Weyandt LL, Oster DR, Gudmundsdottir BG, DuPaul GJ, Anastopoulos AD. Neuropsychological functioning in college students with and without ADHD. Neuropsychology 2017;31:160-72. [PMID: 27831696 DOI: 10.1037/neu0000326] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
644 Joelsson P, Chudal R, Uotila J, Suominen A, Sucksdorff D, Gyllenberg D, Sourander A. Parental psychopathology and offspring attention-deficit/hyperactivity disorder in a nationwide sample. Journal of Psychiatric Research 2017;94:124-30. [DOI: 10.1016/j.jpsychires.2017.07.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
645 Gutiérrez-Casares JR, Quintero J, Jorba G, Junet V, Martínez V, Pozo-Rubio T, Oliva B, Daura X, Mas JM, Montoto C. Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate. Front Psychiatry 2021;12:741170. [PMID: 34803764 DOI: 10.3389/fpsyt.2021.741170] [Reference Citation Analysis]
646 Upadhyaya H, Adler LA, Casas M, Kutzelnigg A, Williams D, Tanaka Y, Arsenault J, Escobar R, Allen AJ. Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine. Child Adolesc Psychiatry Ment Health 2013;7:14. [PMID: 23648011 DOI: 10.1186/1753-2000-7-14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
647 Fedele DA, Lefler EK, Hartung CM, Canu WH. Sex Differences in the Manifestation of ADHD in Emerging Adults. J Atten Disord 2012;16:109-17. [DOI: 10.1177/1087054710374596] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
648 Schein J, Childress A, Adams J, Cloutier M, Gagnon-Sanschagrin P, Maitland J, Bungay R, Guérin A, Lefebvre P. Treatment patterns among adults with attention-deficit/hyperactivity disorder in the United States: a retrospective claims study. Curr Med Res Opin 2021;37:2007-14. [PMID: 34427164 DOI: 10.1080/03007995.2021.1968814] [Reference Citation Analysis]
649 Notzon DP, Mariani JJ, Pavlicova M, Glass A, Mahony AL, Brooks DJ, Grabowski J, Levin FR. Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. Am J Addict 2016;25:666-72. [PMID: 28051838 DOI: 10.1111/ajad.12467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
650 Pohl L, El-Kurdi R, Selinger R, Sauls A, Rhodes LA, Marciniak MW. Implementation of a community-based pharmacist-run attention deficit hyperactivity disorder clinic in a college health center. J Am Pharm Assoc (2003) 2021;61:S178-83. [PMID: 33676837 DOI: 10.1016/j.japh.2021.01.029] [Reference Citation Analysis]
651 Kurdziel LB, Dempsey K, Zahara M, Valera E, Spencer RM. Impaired visuomotor adaptation in adults with ADHD. Exp Brain Res 2015;233:1145-53. [PMID: 25567090 DOI: 10.1007/s00221-014-4190-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
652 Aadil M, Cosme RM, Chernaik J. Mindfulness-Based Cognitive Behavioral Therapy as an Adjunct Treatment of Attention Deficit Hyperactivity Disorder in Young Adults: A Literature Review. Cureus 2017;9:e1269. [PMID: 28775916 DOI: 10.7759/cureus.1269] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
653 Anker E, Haavik J, Heir T. Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: Prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation. World J Psychiatr 2020; 10(9): 202-211 [PMID: 33014721 DOI: 10.5498/wjp.v10.i9.202] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
654 Lugoboni F, Levin FR, Pieri MC, Manfredini M, Zamboni L, Somaini L, Gerra G, Gruppo InterSert Collaborazione Scientifica Gics. Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs. Psychiatry Res 2017;250:210-6. [PMID: 28473157 DOI: 10.1016/j.psychres.2017.01.052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
655 Waite R. Women With ADHD: It Is an Explanation, Not the Excuse Du Jour: Women With ADHD: It Is an Explanation, Not the Excuse Du Jour. Perspectives in Psychiatric Care 2010;46:182-96. [DOI: 10.1111/j.1744-6163.2010.00254.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
656 Knutson KC, O'malley M. Adult attention-deficit/hyperactivity disorder: A survey of diagnosis and treatment practices: Adult ADHD. Journal of the American Academy of Nurse Practitioners 2010;22:593-601. [DOI: 10.1111/j.1745-7599.2010.00546.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
657 Rösler M, Ginsberg Y, Arngrim T, Adamou M, Niemelä A, Dejonkheere J, van Oene J, Schäuble B. Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate. World J Biol Psychiatry 2013;14:282-90. [PMID: 21517701 DOI: 10.3109/15622975.2011.571283] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
658 Ford JD, Connor DF. ADHD and posttraumatic stress disorder. Curr Atten Disord Rep 2009;1:60-6. [DOI: 10.1007/s12618-009-0009-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
659 Cardullo S, Gómez Pérez LJ, Cuppone D, Sarlo M, Cellini N, Terraneo A, Gallimberti L, Madeo G. A Retrospective Comparative Study in Patients With Cocaine Use Disorder Comorbid With Attention Deficit Hyperactivity Disorder Undergoing an rTMS Protocol Treatment. Front Psychiatry 2021;12:659527. [PMID: 33841218 DOI: 10.3389/fpsyt.2021.659527] [Reference Citation Analysis]
660 Mayer K, Blume F, Wyckoff SN, Brokmeier LL, Strehl U. Neurofeedback of slow cortical potentials as a treatment for adults with Attention Deficit-/Hyperactivity Disorder. Clinical Neurophysiology 2016;127:1374-86. [DOI: 10.1016/j.clinph.2015.11.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
661 Somer E, Soffer-Dudek N, Ross CA. The Comorbidity of Daydreaming Disorder (Maladaptive Daydreaming). J Nerv Ment Dis 2017;205:525-30. [PMID: 28598955 DOI: 10.1097/NMD.0000000000000685] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
662 Stern A, Malik E, Pollak Y, Bonne O, Maeir A. The Efficacy of Computerized Cognitive Training in Adults With ADHD: A Randomized Controlled Trial. J Atten Disord 2016;20:991-1003. [PMID: 24756172 DOI: 10.1177/1087054714529815] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
663 Molife C, Bernauer MJ, Farr AM, Haynes VS, Kelsey D. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations. Postgrad Med 2012;124:7-22. [PMID: 23095422 DOI: 10.3810/pgm.2012.09.2586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
664 Wernicke J, Li M, Sha P, Zhou M, Sindermann C, Becker B, Kendrick KM, Montag C. Individual differences in tendencies to attention-deficit/hyperactivity disorder and emotionality: empirical evidence in young healthy adults from Germany and China. ADHD Atten Def Hyp Disord 2019;11:167-82. [DOI: 10.1007/s12402-018-0266-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
665 Weisler RH, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress AC. Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate. Neuropsychiatr Dis Treat 2014;10:1-12. [PMID: 24363557 DOI: 10.2147/NDT.S47087] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
666 Dai H, Jackson CR, Davis GL, Blakely RD, McMahon DG. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model. J Neurodev Disord 2017;9:38. [PMID: 29281965 DOI: 10.1186/s11689-017-9215-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
667 Juul S, Poulsen S, Lunn S, Sørensen P, Jakobsen JC, Simonsen S. Short-term versus long-term psychotherapy for adult psychiatric disorders: a protocol for a systematic review with meta-analysis and trial sequential analysis. Syst Rev 2019;8:169. [PMID: 31301732 DOI: 10.1186/s13643-019-1099-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
668 Kollins SH, English JS, Itchon-Ramos N, Chrisman AK, Dew R, O'Brien B, McClernon FJ. A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD. J Atten Disord 2014;18:158-68. [PMID: 22508760 DOI: 10.1177/1087054712440320] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
669 Bryant AM, Lee E, Howell A, Morgan B, Cook CM, Patel K, Menatti A, Clark R, Buelow MT, Suhr JA. The vulnerability of self-reported disability measures to malingering: a simulated ADHD study. The Clinical Neuropsychologist 2017;32:109-18. [DOI: 10.1080/13854046.2017.1346145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
670 Ma Y, Krueger JJ, Redmon SN, Uppuganti S, Nyman JS, Hahn MK, Elefteriou F. Extracellular norepinephrine clearance by the norepinephrine transporter is required for skeletal homeostasis. J Biol Chem 2013;288:30105-13. [PMID: 24005671 DOI: 10.1074/jbc.M113.481309] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
671 Sumitomo A, Saka A, Ueta K, Horike K, Hirai K, Gamo NJ, Hikida T, Nakayama KI, Sawa A, Sakurai T, Tomoda T. Methylphenidate and Guanfacine Ameliorate ADHD-Like Phenotypes in Fez1-Deficient Mice. Mol Neuropsychiatry. 2018;3:223-233. [PMID: 29888233 DOI: 10.1159/000488081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
672 Greenwood TA, Joo EJ, Shekhtman T, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Kelsoe JR. Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2013;162B:137-45. [PMID: 23255304 DOI: 10.1002/ajmg.b.32108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
673 Schuler J, Weiss NT, Chavira DA, McGough JJ, Berrocal M, Sheppard B, Vaglio E, Fournier E, Herrera LD, Mathews CA. Characteristics and comorbidity of ADHD sib pairs in the Central Valley of Costa Rica. Compr Psychiatry 2012;53:379-86. [PMID: 21696714 DOI: 10.1016/j.comppsych.2011.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
674 Rigler T, Manor I, Kalansky A, Shorer Z, Noyman I, Sadaka Y. New DSM-5 criteria for ADHD - Does it matter? Compr Psychiatry 2016;68:56-9. [PMID: 27234183 DOI: 10.1016/j.comppsych.2016.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
675 Wilens TE, Morrison NR. Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London) 2012;2:301-12. [PMID: 23105949 DOI: 10.2217/npy.12.39] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
676 Ozdemiroglu F, Karakus K, Memis CO, Sevincok L, Mersin S. Temperament in Adulthood Attention Deficit-Hyperactivity Disorder without Bipolar Disorder. Psychiatry Investig 2018;15:266-71. [PMID: 29475238 DOI: 10.30773/pi.2017.06.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
677 Newcorn JH, Stark JG, Adcock S, Mcmahen R, Sikes C. A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults. Clinical Therapeutics 2017;39:1695-705. [DOI: 10.1016/j.clinthera.2017.07.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
678 Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006;256:i26-31. [DOI: 10.1007/s00406-006-1004-4] [Cited by in Crossref: 159] [Cited by in F6Publishing: 138] [Article Influence: 9.9] [Reference Citation Analysis]
679 Wynchank DS, Bijlenga D, Lamers F, Bron TI, Winthorst WH, Vogel SW, Penninx BW, Beekman AT, Kooij JS. ADHD, circadian rhythms and seasonality. J Psychiatr Res 2016;81:87-94. [PMID: 27423070 DOI: 10.1016/j.jpsychires.2016.06.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
680 Retz W, Ginsberg Y, Turner D, Barra S, Retz-Junginger P, Larsson H, Asherson P. Attention-Deficit/Hyperactivity Disorder (ADHD), antisociality and delinquent behavior over the lifespan. Neurosci Biobehav Rev 2021;120:236-48. [PMID: 33271164 DOI: 10.1016/j.neubiorev.2020.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
681 Titus JC, Dennis ML, Lennox R, Scott CK. Development and validation of short versions of the internal mental distress and behavior complexity scales in the Global Appraisal of Individual Needs (GAIN). J Behav Health Serv Res 2008;35:195-214. [PMID: 18286375 DOI: 10.1007/s11414-008-9107-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
682 Stefanatos GA, Baron IS. Attention-deficit/hyperactivity disorder: a neuropsychological perspective towards DSM-V. Neuropsychol Rev 2007;17:5-38. [PMID: 17318413 DOI: 10.1007/s11065-007-9020-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
683 Rostain AL. Adult ADHD and depressive disorders: prevalence, significance, and clinical presentation. CNS Spectr 2008;13:8-10. [PMID: 18567132 DOI: 10.1017/s1092852900002959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
684 Cândido RCF, Menezes de Padua CA, Golder S, Junqueira DR. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 2021;1:CD013011. [PMID: 33460048 DOI: 10.1002/14651858.CD013011.pub2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
685 Wood WLM, Lewandowski LJ, Lovett BJ. Profiles of Diagnosed and Undiagnosed College Students Meeting ADHD Symptom Criteria. J Atten Disord 2021;25:646-56. [PMID: 30744469 DOI: 10.1177/1087054718824991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
686 Sherwood DA, Rey JA. Pharmacological Agents for the Treatment of Adult Attention Deficit Hyperactivity Disorder: A Review of the Literature. Journal of Pharmacy Practice 2006;19:336-41. [DOI: 10.1177/0897190007300727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
687 Clemow DB, Bushe CJ. Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. J Psychopharmacol 2015;29:1221-30. [DOI: 10.1177/0269881115602489] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 4.9] [Reference Citation Analysis]
688 Stevens AA, Maron L, Nigg JT, Cheung D, Ester EF, Awh E. Increased sensitivity to perceptual interference in adults with attention deficit hyperactivity disorder. J Int Neuropsychol Soc 2012;18:511-20. [PMID: 22433515 DOI: 10.1017/S1355617712000033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
689 Pott SL, Delgadillo J, Kellett S. Is behavioral activation an effective and acceptable treatment for co-occurring depression and substance use disorders? A meta-analysis of randomized controlled trials. J Subst Abuse Treat 2021;132:108478. [PMID: 34146994 DOI: 10.1016/j.jsat.2021.108478] [Reference Citation Analysis]
690 Andersen SM, Randers A, Jensen CM, Bisgaard C, Steinhausen HC. Preceding diagnoses to young adult bipolar disorder and schizophrenia in a nationwide study. BMC Psychiatry 2013;13:343. [PMID: 24359146 DOI: 10.1186/1471-244X-13-343] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
691 Riglin L, Agha SS, Eyre O, Bevan Jones R, Wootton RE, Thapar AK, Collishaw S, Stergiakouli E, Langley K, Thapar A. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood. Psychiatry Res 2021;301:113984. [PMID: 33991992 DOI: 10.1016/j.psychres.2021.113984] [Reference Citation Analysis]
692 Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33:159-80. [PMID: 20159345 DOI: 10.1016/j.psc.2009.12.004] [Cited by in Crossref: 249] [Cited by in F6Publishing: 215] [Article Influence: 20.8] [Reference Citation Analysis]
693 Mitchell JT, Van Voorhees EE, Dennis MF, McClernon FJ, Calhoun PS, Kollins SH, Beckham JC. Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder. Nicotine Tob Res 2012;14:986-92. [PMID: 22180583 DOI: 10.1093/ntr/ntr245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
694 Davis C, Cohen A, Davids M, Rabindranath A. Attention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex. Front Psychiatry 2015;6:47. [PMID: 25941494 DOI: 10.3389/fpsyt.2015.00047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
695 Poysophon P, Rao AL. Neurocognitive Deficits Associated With ADHD in Athletes: A Systematic Review. Sports Health 2018;10:317-26. [PMID: 29337649 DOI: 10.1177/1941738117751387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
696 Arnold G, Depew B. School starting age and long‐run health in the United States. Health Economics 2018;27:1904-20. [DOI: 10.1002/hec.3810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
697 Kömürcü E, Bi̇lgi̇ç A, Hergüner S. Relationship between Extremity Fractures and Attention-Deficit/Hyperactivity Disorder Symptomatology in Adults. Int J Psychiatry Med 2014;47:55-63. [DOI: 10.2190/pm.47.1.e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]